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Singapore grouper iridovirus (SGIV), an iridovirus in the genus Ranavirus, is a major 
pathogen that results in significant economic losses in grouper aquaculture. In this 
thesis, first, we report the temporal and differential gene expression of SGIV using 
SGIV viral DNA microarray; Second, we report the first proteomics study of grouper 
embryonic cells (GEC) infected by Singapore grouper iridovirus (SGIV) to take an 
insight into the interaction of SGIV and its host cell at proteome scale by iTRAQ; 
third, we report that a novel viral coding protein ORF158L is involved in the 
regulation of host histone H3 K79 methylation; finally, we report the structural study 
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Chapter One  
Introduction & Literature Review 
 2 
1.1 Overview 
As early as 1898, Friedrich Loeffler and Paul Frosch raised the first clue on the nature 
of virus by demonstrating that the cause of the foot-and-mouth disease in livestock 
was an infectious particle smaller than any known bacteria. Later on, people found 
that viruses had protein coats named virus capsids and genomic contents inside the 
virus. The materials for storage of the genomic information of the virus could be 
either DNA or RNA. Based on the materials of the genomic content of the viruses, the 
viruses can be classified into two major groups, i.e. DNA viruses and RNA viruses. 
Viruses are further classified into single-stranded DNA (ssDNA), single-stranded 
RNA (ssRNA) viruses and double-stranded DNA (dsDNA) viruses. The dsDNA 
viruses are further classified into more than 20 families.  
1.2 Introduction of Iridovirus 
The Iridoviridae Family is one member of the DNA virus families. Iridoviruses are 
large cytoplasmic DNA viruses and infect either insects or vertebrates. In 1954, the 
first iridovirus was discovered by Smith and Xeros (Smith and Xeros, 1954). To date, 
more than 100 iridoviruses belonging to the four genera of the iridovirus family have 
been isolated. The four genera of the iridovirus family are Iridovirus, Chloriridovirus 
and, Lymphocystivirus and Ranavirus (Chinchar et al., 2005).  
1.3 Introduction of Singapore grouper iridovirus (SGIV) 
In 1994, a novel member of Ranavirus, Singapore grouper iridovirus (SGIV), causing 
significant economic losses in Singapore marine net cage farm was reported (Chua et 
al., 1994). In 1998, SGIV was isolated from brown groupers (Qin et al., 2001). In 
2004, the genomic DNA of SGIV was sequenced and 162 open reading frames (ORFs) 
were predicted based on genomic sequence (Song et al., 2004). Until 2006, a total of 
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61 SGIV structural proteins had been identified by using proteomics methods (Song et 
al., 2004; Song et al., 2006).  
1.4 Transcriptional regulation and replication cycle of iridovirus 
Transcriptional regulation of viral gene expression is one of the important subjects in 
viral research. In 2001, the gene expression of Chilo iridescent virus (CIV), was 
investigated and 137 viral transcripts were detected (D’Costa et al., 2001). Two years 
later, Costa and coworkers further investigated the transcriptional mapping of the CIV 
and found that 90 percent of the CIV genome encoding genes were transcripted 
(D’Costa et al., 2004 ). The transcriptional program of CIV was studied by Costa and 
coworkers using traditional methods, such as Northern blot (D’Costa et al., 2001; 
D’Costa et al., 2004 ). Compared to Northern blot, the DNA microarray technology is 
a newly emerging high through put methodology. DNA microarray can be used to 
investigate hundreds, even thousands of genes simultaneously. Therefore, DNA 
microarray can provide a better understanding of viral transcriptional programs. DNA 
microarray has been widely used in viral gene transcriptional studies in the past 
decade. Recently, in 2005, Lua and coworkers applied DNA microarray technology to 
reveal the transcriptional programs of red sea beam iridovirus (RSIV) by monitoring 
92 putative ORFs simultaneously (Lua et al., 2005 ). In 2007, similar work was 
reported on the transcriptional profile of RSIV using DNA microarray and found that 
97-99% of the RSIV ORFs were expressed (Lua et al., 2007). However, the gene 
expression and transcriptional program of SGIV has not been investigated either by 
Northern blot or DNA microarray. The study of the transcriptional profile of SGIV 
may provide a profound insight into the replication and pathogenesis of the iridovirus 
family.   
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The replication cycle of the iridovirus is very complicated and not fully understood. 
Murti and coworkers proposed a model to elucidate the replication cycle of the 
iridovirues(Murti et al., 1985). The first step of the replication cycle of iridovirus 
particles is that iridovirus particles attach to the plasma membranes of host cells. After 
attaching to membrane, the viral particles enter the host cells by phagocytosis (the 
cellular process by which cell membrane engulfs solid particles to form an internal 
phagosome.). Subsequent to the entry, the iridovirus particles are delivered to the 
lysosomes of host cells, and they are uncoated inside the lysosomes. As a result, the 
genome of iridoviruses is released. The released iridovirus genome is transported to 
the host nucleus and the first stage of iridovirus genome replication is initiated. At the 
same time, the iridovirus immediate early genes are transcribed, and the iridovirus 
genome is transported to the cytoplasm of the cell and the iridovirus commences its 
second stage genome replication in the cytoplasm. Besides, the early and late genes of 
the iridoviruse are transcripted and translated. The genomes and structural proteins of 
the iridoviruse begin to assemble to form new iridoviruses, and are released from the 
host cells. The virus is now ready to initiate new replication cycles (Figure 1.1) (Murti 
et al., 1985).  
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1.5 Functional genomics  
1.5.1 Introduction of Functional genomics 
Genomic projects, such as genome sequencing projects, have produced a vast wealth 
of data. Functional genomics is a field of molecular biology that attempts to describe 
large scale gene/protein functions and interactions by using the data produced by 
genomic projects. Functional genomics focuses on the dynamic aspects such as gene 
transcription, translation, and protein-protein interactions. 
1.5.2 Gene expression profile and differential gene expression of the iridovirus 
In the iridovirus replication cycle, the iridovirus genes are differentially expressed 
(Williams, 1996). On one hand, some iridovirus genes are expressed at the first stage 
of iridovirus genome replication in the nucleus of host cells. On the other hand, some 
genes are expressed after the first stage of iridovirus genome replication. According to 
the differential gene expression of iridoviruses, the iridoviruses genes are divided into 
three groups: the immediate early genes, the early genes and the late genes. The 
immediate early genes are expressed immediately after the primary infection, and 
these genes encode proteins which play important roles in the trans-activation of 
iridoviruses. Following the expression of the immediate early genes, the early genes 
are expressed, and they encode proteins which play important roles in the iridovirus 
genome replication. After the onset of the iridovirus genome replication, the late 
genes are expressed, and they encode structural proteins of iridovirus particles. Given 
the different functions of the three groups of iridovirus genes, the study on the 
temporal and differential gene expression of iridoviruses can provide important 
information on the pathogenesis mechanism of iridoviruses.    
The gene expression profile and differential gene expression of iridoviruses are poorly 
studied. In 2001, D’ Coasta and coworkers studied the differential gene expression of 
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Chilo iridescent virus (D’Costa et al., 2001). They reported 137 detectable transcripts , 
and classified these 137 transcripts into 3 groups: 38 immediate-early gene transcripts, 
34 early gene transcripts and 65 late gene transcripts. Three years later, D’ Coasta and 
coworkers further reported that more than 90 percent of the Chilo iridescent virus 
genome was transcriptional active (D’Costa et al., 2004). The differential gene 
expression of Chilo iridescent virus was studied by using the Northern blot (D’Costa 
et al., 2001; D’Costa et al., 2004 ). The Northern blot can only study one gene per 
time, and it is a low-throughput method used in gene expression studies. Compared to 
Northern blot, DNA microarray is a newly emerging high-throughput technology. 
DNA microarray can be used to study hundreds, even thousands, of genes 
simultaneously. DNA microarray was used to study differential gene expression of 87 
genes of the red sea beam iridovirus in grunt fin cells in 2005 (Lua et al., 2005).  By 
using DNA microarray, Lua and coworkers reported that as early as 3 hour 
postinfection, some genes of the red sea beam iridovirus commenced expression. 
After 8 hour postinfection, a rapid escalation of gene expression of the red sea beam 
iridovirus was described. Furthermore, the gene expression of red sea beam iridovirus 
was differentiated by using a de novo protein synthesis inhibitor (cycloheximide) and 
a viral DNA replication inhibitor (phosphonoacetic acid). The differential gene 
expression of the red sea beam iridovirus revealed that the 87 RSIV transcripts were 9 
immediate-early gene transcripts, 40 early gene transcripts and 38 late gene transcripts. 
In addition, in 2007, Lua and coworkers reported the gene expression profiles of the 
red sea beam iridovirus in infected fish (Lua et al., 2007). Although RSIV transcripts 
had been investigated by DNA microarray, many redundant data entries were 
included. Additionally, the genomic sequence of RSIV can not be found in the NCBI 
database. From the literature (Lua et al. 2005; Lua et al., 2007), we can only identify 
 7 
around 10 unique conserved ORFs between RSIV and SGIV based on the functional 
description of viral ORFs. Based on the limited descriptions about RSIV from the 
Lua's paper, the RSIV could be similar to Rock bream iridovirus (RBIV) which is a 
member of the Megalocytivirus genus, while SGIV is a member of Ranavirus. 
Besides the 26 iridoviridae core genes, which are conserved among iridovirus, only 
two other ORFs in Megalocytivirus have orthologs in Ranavirus (Eaton et al., 2007). 
Thus, it would be valuable to investigate the gene expression profile as well as 
differential gene expression of SGIV.  
1.5.3 Functional genomics studies at proteomics scale by using iTRAQ 
Functional genomics studies provide information, which should be useful to 
understand complex biological systems. These studies, quite often, involve 
differential comparison of expression with reference to a control state. Although tools 
like nucleic acid microarrays are widely used to perform the differential comparison 
of expression in gene transcriptional levels, these tools do not directly give indications 
in the gene translational levels. Differences in gene expression do not necessarily 
correspond directly to differences in protein expression, due to the following 
arguments: I) Expression of proteins is regulated by the combination of transcription 
rates and mRNA degradation rates, and is not evidently obvious from mRNA levels; 
II) The protein concentrations are not always consistent with mRNA concentrations; 
III) Many differential effects on proteins themselves come from post-translational 
modifications such as phosphorylation or glycosylation, and these effects cannot be 
measured or identified by looking at the mRNA levels (Zieske, 2006). More 
importantly, compared to nucleic acid expression, proteins are effector molecules. As 
a result, the investigation of differential expression at protein levels will contribute to 
a better understanding of biological systems.  
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There are several technologies used to assess more accurately protein levels between 
different biological states. I ) 2D-gel: In the 2D-gel technique, differentially expressed 
spots are excised and analyzed by mass spectrometry (MS). The disadvantages of 2D-
gel technique are: ① Not all types of proteins are amenable to gels; ② The dynamic 
range is somewhat limited; ③The low-abundance proteins are difficult to identify; ④ 
The resolution is restricted; ⑤ The throughput is relatively low. II ) chip-based MS: 
the chip-based MS approaches have a relatively higher throughput, but the actual 
identification of the proteins of interest is time-consuming, often relying on off-line 
techniques to purify the potential marker(s) implied by the qualitative information 
from the MS analyses. III ) Chromatographic approaches:  Chromatographic 
approaches are subject to diminished sample throughput as well as reproducibility 
between samples and replicates. IV ) ICAT:  The ICAT stands for Isotope Coded 
Affinity Tags (Gygi et al., 1999). In this approach, two samples are labeled with 
chemically identical tags that differ only in isotopic composition (heavy and light 
pairs) and contain a thiol-reactive group (which covalently links to cysteine residues) 
and a biotin moiety. The limitations of ICAT are:  ① The ICAT reagents can only be 
used to analyze protein peptides that contain a cysteine residue; As a result, many 
important proteins, including those with post-translational modifications, are 
overlooked by this technique; ② The ICAT can only be used to compare only two 
samples. V )  SILAC, which stands for Stable Isotope Labeling by Amino Acids in 
Cell Culture (Ong et al., 2002). This method incorporates isotopic labels into proteins 
via metabolic labeling in the cell culture itself, rather than using a covalently linked 
tag. Thus, cell samples to be compared are grown separately in media containing 
either a heavy or light form of an essential amino acid (e.g. one that cannot be 
synthesized by the cell). The advantages of SILAC are that it has a higher fidelity than 
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ICAT (incorporating nearly 100% efficiency) and does not require multiple chemical 
processing and purification steps, thus ensuring that the samples to be compared have 
been subjected to similar conditions throughout the experiment. This approach, 
however, requires viable active cell lines to allow for the incorporation of the 
respective heavy/light amino acids into the protein samples, and may not always be 
available for all experimental samples.  
Despite the broad range of biological questions that the above approaches have 
successfully addressed, there is still a need for additional technologies that can carry 
out global peptide labeling, retention of post-translational modification (PTM) 
information, and simultaneous multiplexed (more than two samples) analyses. iTRAQ, 
a new technique stands for Isobaric Tags for Relative and Absolute Quantitation, was 
firstly developed by  Darryl Pappin and colleagues at Applied Biosystems in 2004 
(Ross et al., 2004), and can be used to label four samples simultaneously . This 
unique approach labels samples with four independent reagents of the same mass that, 
upon fragmentation in MS/MS, give rise to four unique reporter ions (m/z =114–117) 
that are subsequently used to quantify the four different samples, respectively.  To 
date, iTRAQ can label samples with eight independent reagents of the same mass that, 
upon fragmentation in MS/MS, give rise to eight unique reporter ions (m/z=113-121) 
that are subsequently used to quantify the eight different samples. Figure 1.2 shows 
the chemical design of iTRAQ reagents. Figure 1.3 shows the workflow of iTRAQ 
experiments to investigate differential protein expression among samples. The amine 
specificity of these reagents makes most peptides in a sample amenable to this 
labeling strategy with no loss of information even from samples involving post-
translational modifications, such as the scrutiny of signal transduction pathways that 
often involve phosphorylation. In addition, the multiplexing capacity of these reagents 
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allows for information replication within certain LC-MS/MS experimental regimes, 
providing additional statistical validation within any given experiment.  
1.6 Structural genomics 
1.6.1 Introduction of structural genomics 
Structural genomics is the determination of the three dimensional structures of all 
proteins of a given organism, by experimental methods such as X-ray crystallography, 
NMR spectroscopy or computational approaches such as homology modeling. The 
complete sequencing of several genomes has provided us the protein repertories of 
diverse organisms from all kingdoms (Green, 2001; Aparicio et al., 2002; Marsden et 
al., 2006.). The challenge of understanding these gene products has led to the 
development of functional genomics methods, which collectively aim to annotate the 
raw sequence with biological understanding (Brenner, 2001). Structural genomics is 
one such approach, with a unique promise to reveal the molecular function of protein 
domains (Ashburner et al., 2000).  
1.6.2 NMR spectroscopy 
Nuclear magnetic resonance (NMR), which is a physical phenomenon based upon the 
quantum mechanical magnetic properties of an atom's nucleus, also commonly refers 
to the methods that exploit nuclear magnetic resonance to study molecules. In 1938,  
Isidor Rabi first described and measured the nuclear magnetic resonance in molecular 
beams (Rabi et al., 1938). Eight years later, in 1946, Felix Bloch and Edward Mills 
Purcell refined the technique for use on liquids and solids (Bloch et al., 1946; Purcell 
et al., 1946), for which they shared the Nobel Prize in physics in 1952. In 1953, 
Overhauser defined the concept of nuclear overharser effect (NOEs) as the basis for 
structural determination by NMR (Overhauser, 1953). Three decades later, in 1985, 
the first solution-state protein structure was reported by applying the NMR in solving 
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protein structure (Williamson et al., 1985). Since then, NMR has become an 
alternative method to X-ray crystallography for the structural determination of small 
to medium sized proteins (<25kDa) in aqueous or micellar solutions. In recent years, 
an impressive number of advances in biomolecular NMR spectroscopy have been 
reported (Wider and Wüthrich, 1999; Fiaux et al., 2002; Fernandez and Wider, 2003). 
NMR has emerged as a powerful probe for the study of protein structure (Clore and 
Gronenborn, 1991; Sattler et al., 1999; Bax, 2003) and dynamics (Ishima and Torchia, 
2000; Bruschweiler, 2003). In particular, studies of proteins with molecular mass on 
the order of 100 kDa are now possible at a level of detail that was previously reserved 
for much smaller systems (Kay, 2005). In general, the main procedures of structure 
determination by NMR are sample preparation, data acquisition, data processing, data 
assignments and structural calculations. 
1.6.3 X-Ray crystallography 
X-ray crystallography is the science of determining the arrangement of atoms within a 
crystal from the manner in which a beam of X-rays is scattered by the electrons within 
the crystal. The method produces a three-dimensional density of electrons within the 
crystal, from which the mean atomic positions, their chemical bonds, their disorder 
and much other information can be derived. By definition, a crystal is a solid in which 
a desired minimum volume containing particular arrangement of atoms (its unit cell) 
is repeated indefinitely along three principal directions known as the basis (or lattice) 
vectors. 
Three dimensional protein structures at atomic level can be determined by X-ray 
crystallography. Growth of single well-defined diffracting crystal forms the basic and 
essential prerequisite for X-ray crystallography to determine protein structures (Blow, 
2002).  The bottleneck to structure determination by X-ray crystallography is the 
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generation of high quality crystals (Chayen, 2004). In the late 1950’s, crystal 
structures of proteins began to be solved, beginning with the structure of sperm whale 
myoglobin by Max Perutz and Sir John Cowdery Kendrew, for which they were 
awarded the Nobel Prize in Chemistry in 1962 (Kendrew et al., 1958). To date, 
~39000 crystal structures of proteins have been determined by X-ray crystallography 
(http://www.rcsb.org/pdb/statistics/holdings.do). For comparison, the nearest 
competing method, NMR spectroscopy has produced roughly 6000 structures 
(http://www.rcsb.org/pdb/statistics/holdings.do). X-ray crystallography is now used 
routinely by scientists to determine how a pharmaceutical compound interacts with its 
protein target and what changes might be advisable to improve it (Scapin, 2006).  
1.7 Scope of thesis 
In this thesis, we will present  
1) The study of temporal and differential gene expression of SGIV using DNA 
microarray.  
2) The proteomics study of grouper embryonic cells infected by SGIV using iTRAQ.  
3) The functional study of ORF158L, a novel protein coded by SGIV genome.  













Figure 1.2. The chemical structure of an iTRAQ reagent. A) Design of the iTRAQ 
reagents-4plex consists of a charged reporter group, a peptide reactive group, and a 
neutral balance portion to maintain an overall mass of 145 (Zieske and Lynn, 2006). B) 
Design of the iTRAQ Reagents - 8plex consists of a charged reporter group, a peptide 
reactive group, and a neutral balance portion to maintain an overall mass of 305 
(http://www.appliedbiosystems.com.sg). (Isobaric, by definition, implies that any two 






Fig. 1.3. Workflows of iTRAQ experiments. Once labeled with the iTRAQ Reagents, 
the individual samples are then be pooled for further processing and analysis. During 
subsequent MS/MS of the peptides, each isobaric tag produces a unique reporter ion 
that identifies which samples the peptide originated and its relative abundance. A) 
General scheme of a multiplex reaction of four different samples (S1–S4), designated 
by four different colors(Zieske and Lynn, 2006). B) General scheme of a multiplex 
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Singapore grouper iridovirus (SGIV), an iridovirus in the genus Ranavirus, is a major 
pathogen that results in significant economic losses in grouper aquaculture. To 
investigate further its infective mechanisms, for the first time, a viral DNA microarray 
was generated for the SGIV genome to measure the expression of its predicted open 
reading frames simultaneously in vitro. By using the viral DNA microarray, the 
temporal gene expression of SGIV was characterized and the DNA microarray data 
were consistent with the results of real-time RT-PCR studies. Furthermore, different-
stage viral genes (i.e. immediate-early, early and late genes) of SGIV were uncovered 
by combining drug treatments and DNA microarray studies. These results should offer 
important insights into the replication and pathogenesis of iridoviruses.
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2.2 Introduction 
Singapore grouper iridovirus (SGIV) (Chinchar et al., 2005; Williams et al., 2005; 
Song et al., 2004), a novel iridovirus of the genus Ranavirus, is a large, icosahedral, 
cytoplasmic DNA virus. The virus, which causes sleepy grouper disease (SGD), has 
resulted in significant economic losses in marine net-cage farms in Singapore. It was 
isolated successfully in 1998 from diseased brown-spotted grouper, Epinephelus 
tauvina (Chua et al., 1994; Qin et al., 2001). The entire SGIV genome consists of 
140,131 bp, and 162 open reading frames (ORFs), encoding polypeptides varying 
from 41 to 1268 aa, were predicted from the sense and antisense DNA strands (Song 
et al., 2004). These viruses are causative pathogens of serious systematic diseases in 
farms of both feral and cultured groupers. So far, genomic sequences of two grouper 
iridoviruses have been published: SGIV (Song et al., 2004)and grouper iridovirus 
(GIV) (Tsai et al., 2005), with whole-genomic sequence similarity of >90 %. Willis et 
al. (1977) designated 10 ‘early’ RNAs (of 47 mRNAs), expressed from 1 to 1.5 h after 
frog virus 3 (FV-3) infection of fathead minnow cells by using isotopic labelling of 
virus-specific RNA. The RNA transcriptional map of the Wiseana iridescent virus 
(WIV) has been studied by using a combination of [35S]methionine pulse-labelling 
and Northern blotting with WIV DNA probes (McMillan and Kalmakoff, 1994). 
Similarly, the transcriptional map and temporal cascade of Chilo iridescent virus (CIV) 
have been studied by carrying out Northern analyses with several putative CIV gene-
specific probes (D’Costa et al., 2001 ; D’Costa et al., 2004). However, at present, the 
transcriptional program of viral genes in SGIV is still unclear. DNA microarrays 
provide a potential tool for the simultaneous measurement of gene expression in all of 
these viral genes. In this study, we constructed, for the first time, a viral DNA 
microarray covering 127 predicted ORFs of the SGIV genome. By using this SGIV 
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DNA microarray, the transcriptional program of SGIV was uncovered. The temporal 
expression of SGIV genes was further confirmed by real-time RT-PCR. By using 
cycloheximide (CHX) and aphidicoline as inhibitors, the immediate-early (IE), early 
(E) and late (L) viral genes were characterized.
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2.3 Materials and methods 
2.3.1 Cell lines. 
Grouper embryonic (GE) cells from the brown-spotted grouper E. tauvina  (Chew et 
al., 1994) were cultured in Eagle's minimum essential medium containing 10 % fetal 
bovine serum, 0.116 M NaCl, 100 IU penicillin G ml–1 and 100 µl streptomycin 
sulfate ml–1. Culture media were equilibrated with HEPES to a final concentration of 
5 mM and adjusted to pH 7.4 with NaHCO3.  
2.3.2 Positive controls for the SGIV DNA microarray. 
Given that there is no grouper cDNA library available, we partially sequenced cDNAs 
of β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from the GE 
cells and designed unique amplicons for β-actin and GAPDH in the SGIV DNA 
microarray as positive controls. The partial cDNA sequences of grouper β-actin and 
GAPDH are shown in Table 2.3. β-Actin was also used for data normalization.  
2.3.3 Preparation of amplicons for the SGIV DNA microarray. 
One hundred and sixty-two SGIV ORFs were predicted on the basis of the published 
SGIV sequence  (Song et al., 2004). Two rounds of PCR were used to generate the 
amplicons for the microarray. In the first round, specific primers with sizes ranging 
from 18 to 22 bp were generated on the basis of the SGIV full-length genome [8 bp 
universal sequences (TGACCATG), added to the 5' terminal of the forward primers, 
were designed (Table 2.2). The amplicon sizes varied from 200 to 400 bp. Amplicons 
whose BLAST scores against other ORFs exceeded 400 were excluded. The genomic 
DNA of SGIV was used as template in the first round of PCR. In the second round, 
the DNA fragments from the first round were used as template and 5'-amino-modified 
universal primer 5'-GCTGAACAGCTATGACCATG-3' and ORF-specific reverse 
primer were applied. AmpliTaq DNA Polymerase (Applied Biosystems) was used in 
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both rounds of PCR. Each PCR fragment was confirmed to be a single band and of 
the correct size by running on a 2 % agarose gel (data not shown). The final 129 
amplicons, representing 127 viral ORFs and two host housekeeping genes, β-actin and 
GAPDH (purified with a QIAquick 96 PCR Purification Kit; Qiagen), were spotted 
onto lysine-coated slides in duplicate.  
2.3.4 Virus infection and CHX and aphidicoline treatments. 
GE cells were mock-infected or infected with SGIV at an m.o.i. of 3 p.f.u. per cell. To 
investigate the temporal expression of viral genes, total RNA was harvested from 
mock-infected and SGIV-infected GE cells at 0, 1, 4, 8, 16, 32, 48, 72 and 96 h post-
infection (p.i.). CHX, a protein synthesis inhibitor that prevents de novo protein 
synthesis by preventing translation, was used to study the transcription of viral IE 
genes. To assess IE gene transcription, SGIV mock-infected and SGIV-infected 
cultures were treated with different concentrations of CHX (50, 100, 200 or 
500 µg/ml) 1 h before infection. Aphidicoline is a specific inhibitor of DNA 
polymerase α. In the presence of aphidicoline, viral DNA replication is inhibited. 
Given that the L genes were expressed after viral DNA replication, the expression of 
L viral genes would be downregulated compared with those without aphidicoline 
treatment. To examine the viral E genes, the transcriptomes from the cultures with 
aphidicoline treatment and SGIV-infected at 3 p.f.u. per cell were compared with 
those from the culture with mock aphidicoline treatment and SGIV-infected at 3 p.f.u. 
per cell. In the aphidicoline treatment, aphidicoline at a final concentration of 
30 µg ml–1 was added to the culture 1 h prior to SGIV infection.  
2.3.5 Total RNA preparation, reverse transcription and labelling. 
Total RNA was extracted and purified by using a Qiagen RNeasy Mini Kit. RNAsin 
(10 units; Promega), 100 units DNase I and 10 µl enzyme buffer 3 (Roche) were 
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added to the total RNA solution, mixed well and incubated at room temperature for 
20 min. The RNA samples were later purified with a Qiagen RNeasy column and 
stored at –70 °C. For reverse-transcription reactions, 10 mM dATP, 10 mM dGTP, 
10 mM dCTP, 2 mM dTTP (Invitrogen) and 8 mM aa-dUTP (Ambion) were used. For 
each reverse-transcription reaction, 10 µg total RNA was reverse-transcribed by using 
PowerScript Reverse Transcriptase (BD Clontech) with random primers [d(N)6, 
0.5 µg/µl] (Life Technologies). After reverse transcription, the unused aa-dUTPs were 
removed with Microcon YM-30 columns (Amicon). The cDNAs were coupled with 
mono-functional NHS-ester Cy dyes (Amersham Biosciences). After removing 
unincorporated/quenched Cy dyes with a QIAquick PCR purification kit (Qiagen), the 
mixtures were hybridized to the SGIV DNA chip by using the MAUI hybridization 
system (BioMicro Systems) and incubated overnight at 42 °C. The hybridizations 
were repeated on duplicate arrays with independently prepared RNA. The data 
obtained from the different arrays were consistent. The mean correlation coefficient of 
127 viral elements of duplicates was 0.9865. The mean correlation coefficient of 127 
viral elements between repeats was 0.9750.  
2.3.6 Real-time PCR. 
In order to validate the DNA microarray data, semi-quantitative real-time RT-PCR 
was applied and β-actin was used as the control. The specific primers for real-time 
RT-PCR were checked after PCR and showed a single, specific band after running on 
2 % agarose gel. Information on the real-time PCR primers is provided in Table 2.4, 
available in the JGV Online website. The total RNA samples were reverse-transcribed 
using PowerScript Reverse Transcriptase (BD Clontech) with random primers [d(N)6, 
0.5 µg µl–1]. cDNA (50 ng) was subsequently subjected to real-time PCR by using a 
QuantiTect SYBR Green PCR kit (Qiagen) in the Lightcycler 2.0 system (Roche). 
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2.4.1 Viral microarray for grouper iridovirus 
To date, two grouper iridovirus genomes have been sequenced completely (Song et al., 
2004; Tsai et al., 2005). The specificity of the arrays was validated with cDNA probes 
prepared from mock-infected and SGIV-infected GE cells. The cDNA probes from 
uninfected cells detected only β-actin and GAPDH, while cDNA probes from infected 
cells detected all SGIV DNA targets, as well as β-actin and GAPDH (data not shown). 
2.4.2 Temporal gene-expression analysis of the SGIV genome 
Total RNA was harvested from mock-infected cells and SGIV-infected cells at 0, 1, 4, 
8, 16, 32, 48, 72 and 96 h p.i.  
Of the 127 viral elements on the SGIV array, 16 (13 %) of the 127 investigated viral 
ORFs commenced expression at 1 h p.i., 106 (83 %) commenced expression at 4 h p.i. 
and five (4 %) ORFs commenced expression at 8 h p.i. (Table 2.5).  
In our viral DNA microarray, 68 (53.5 %), 43 (34 %), two (1.5 %) and 14 (11 %) of 
the 127 investigated viral ORFs were detected to reach maximum expression at 32, 48, 
72 and 96 h p.i., respectively (Table 2.5).  
Hierarchical clustering, in which the expression of each gene at every time point was 
compared and grouped according to the similarity in gene-expression profiles, was 
applied to examine the relationship between the genes and their expression patterns. A 
coloured mosaic matrix, in which each column represents a time point and each row 
indicates the expression pattern of a single ORF, was used to feature the temporal 
viral gene-expression data generated from our viral DNA microarray. The ordered and 
varied patterns of viral gene expression are illustrated in (Figure 2.1).  
In order to validate the DNA microarray results, semi-quantitative real-time RT-PCR 
was carried out separately to investigate the expression profile of one IE viral gene 
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(ORF086R), one E viral gene (ORF006R) and one L viral gene (ORF072R – major 
capsid protein), with β-actin as controls. The results of real-time RT-PCR were 
consistent with the DNA microarray data (Figure 2.2A–C). The consistency between 
the real-time RT-PCR and viral DNA microarray data supports the general 
applicability and utility of our array approach. 
2.4.3 SGIV viral gene expression with different concentrations of CHX 
We used the DNA microarrays to compare the gene expression of SGIV-infected GE 
cells with that of mock-infected GE cells, both under CHX treatment. The normalized 
data show that SGIV gene expression decreased with increasing concentration of 
CHX (Figure 2.3A–D). This phenomenon suggests that the expression of SGIV viral 
genes does indeed depend on the presence of one or more viral proteins. When the 
viral gene expression was analysed in the presence of 500 µg CHX ml–1, we found 
that 41 (32.3 %) ORFs displayed a 1.3-fold upregulation (listed in Table 2.1). These 
41 ORFs were not sensitive to CHX treatment and were considered as strong IE gene 
candidates (Table 2.1). As expected, the two putative IE genes, namely ORF086R and 
ORF162L, were included in this candidate IE gene list (Table 2.1). 
2.4.4 SGIV viral gene expression with aphidicoline treatment 
In order to classify the remaining SGIV viral genes (except for the SGIV IE gene 
candidates) into E and L genes, aphidicoline treatment was carried out together with 
the simultaneous analysis of all viral transcriptomes. In this study, we compared the 
transcriptomes of SGIV-infected cultures with aphidicoline treatment against those of 
SGIV-infected cultures mock-treated with aphidicoline across time. We found that 
several genes were upregulated (fold >1) and a number of viral genes showed down 
regulation (fold <1) (Figure 2.4A-D). Viral genes that consistently displayed twofold 
down regulation from 16 to 48 h p.i. with aphidicoline treatment were considered to 
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be L gene candidates. After analyzing the aphidicoline treatment across time, we 
found that 50 (38.1 %) ORFs consistently displayed twofold down regulation and 
were considered to be candidates for viral L genes (Table 2.1). 
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2.5 Discussion 
Our investigation focused on the expression patterns of SGIV genes with both known 
and unknown functions and offers new insights into virus replication and pathogenesis. 
When the double time (DT), which means the time (h p.i.) at which the expression of a 
viral gene, for the first time, showed a twofold upregulation compared with baseline 
expression (0 h p.i.) (Paulose et al., 2001), was analysed, ORF086R, a putative IE 
gene, commenced its expression as early as 1 h p.i., DNA replication- and 
transcription-related genes, for example DNA polymerase (ORF128R) and the two 
largest subunits of DNA-dependent RNA polymerase II (ORF073L and ORF104L), 
increased their expression levels at 4 h p.i. and the major capsid protein (ORF072R) 
commenced expression as late as 8 h p.i. (Table 2.5). These results indicate that SGIV 
replication may proceed through a strictly temporally ordered transcriptional program. 
These results are consistent with the notion, based on FV-3, that one or more IE 
proteins are needed to activate viral E gene transcription and that one or more viral E 
proteins are required to switch on viral L gene transcription (Willis et al., 1977; 
Williams et al., 2005).  
Another interesting finding is that SGIV genes vary in their peak time (PT), which is 
defined as the time (h p.i.) at which the transcript of a viral gene accumulates to its 
maximum amount. The PTs of SGIV genes range from 32 to 96 h p.i. (Table 2.5). No 
relationship was found between the functions of SGIV genes and their PTs. Although 
IE and E genes were expressed earlier than L genes in the SGIV replication cycle, the 
abundances of all SGIV genes' transcriptomes in the host cell after 8 h p.i. were 
substantial. These results are consistent with the earlier observations in FV-3 and CIV 
(Chinchar and Yu, 1992; Chinchar et al., 1994; D’Costa et al., 2001).  
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When the gene tree was analysed, some of the viral ORFs encoding viral structural 
proteins clustered together at the top of the gene tree. These include ORF072R, 
encoding the viral major capsid protein, ORF019R, encoding a myristylated 
membrane protein, ORF141R, encoding a glycoprotein, and another two ORFs, 
ORF009L and ORF007L, encoding two proteins of unknown function that have been 
identified from the mature viral particles by mass spectrometry (Song et al., 2006). 
The clustering gene tree also shows a tendency for genes with similar functions, such 
as ORF029L and ORF131R, both of which encode homologues of the Ig-like domain, 
to be clustered together, despite being located apart from each other in the viral 
genome. In the SGIV genome, a number of viral genes are novel and their function is 
unknown. It has been reported that the co-expression of genes of known function with 
novel genes may provide a relatively simple means to postulate the functions of these 
poorly characterized ones (Eisen et al., 1998). 
It has been reported that the IE, E and L transcripts of FV-3 were synthesized in three 
coordinated phases (Willis et al., 1977.; Willis and Granoff, 1978). Similarly, SGIV 
genes can be classified as IE genes, E genes and L genes. CHX-insensitive SGIV 
genes are suggested to be IE genes. Aphidicoline-sensitive SGIV genes are suggested 
to be L genes. When combining the results of CHX and aphidicoline treatments, the 
127 SGIV elements on the microarray included 28 (22.1 %) IE genes, 49 (38.6 %) E 
genes, 37 (29.1 %) L genes and 13 (10.2 %) unclassified genes (Table 2.1).  
Early viral transcripts contain IE and E viral genes. It has been proposed that E 
transcripts in FV-3 encode regulatory proteins and key catalytic enzymes (Goorha et 
al., 1978; Goorha, 1982; Williams et al., 2005). Similar observations were made for 
SGIV. SGIV E transcripts contain replication-related genes, e.g. DNA polymerase 
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(ORF128R), as well as transcription-related genes, such as the second-largest subunit 
of DNA-directed RNA polymerase II (ORF073L).  
Although combining DNA microarrays and drug treatments can provide a wealth of 
information concerning the expression profile of different viral genes, the approach 
has some inherent limitations. For example, in the list of unclassified ORFs, 
ORF019R and ORF141L, which encode two structural proteins (a myristylated 
membrane protein and a glycoprotein, respectively), are insensitive to the CHX 
treatments, even at high concentrations (500 µg ml–1) and ORF146L, encoding 
NTPase/helicase, shows a high sensitivity to the aphidicoline treatment. The possible 
mechanisms behind drug sensitivity or resistance of these unclassified SGIV genes 
need further investigation.  
When investigating the temporal expression of different-stage genes, we found that 
the IE genes commenced expression between 1 and 4 h p.i., most of the E genes 
commenced expression at 4 h p.i. and most of the L genes commenced expression 
between 4 and 8 h p.i. The expression of three of the E genes (ORFs 83R, 099R and 
111R) and seven of the L genes (ORFs 008L, 010L, 021L, 055R, 089L, 116R and 
154R) was found to increase as early as 1 h p.i. The functions of these viral E and L 
genes are still unknown.  
We also found several interesting phenomena in SGIV. First, ORF030L, which was 
predicted to be a virus tegument protein (a structural protein), showed insensitivity to 
both CHX and aphidicoline. ORF030L might have other functions besides being a 
tegument protein of SGIV. Second, the SGIV genome contained: (i) ORF144R, 
encoding a homologue of the FGF (fibroblast growth factor) 22 of rat, a major active 
species of presynaptic organizing molecule (Umemori et al., 2004), (ii) ORF145R, 
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encoding a homologue of the mouse FGF 10, which is related closely to FGF 22 
(Tagashira et al., 1997; Okazaki et al., 2002; Strausberg et al., 2002; Umemori et al., 
2004). FGF 22 and FGF 10 play important roles in presynaptic differentiation 
(Umemori et al., 2004). Expression of FGF homologues by SGIV may play an 
important role in forming the clinical symptoms of SGIV-infected groupers.  
Although it has been reported that SGIV is an enveloped virus that enters cells by 
endocytosis to start the viral infection cycle and buds from the plasma membrane in 
the late infection phage (Qin et al., 2001), little is known about the processes that 
occur during SGIV infection. By combining the results of SGIV temporal gene-
expression profiles and different-stage viral genes, the patterns of different-stage viral 
gene expression are uncovered. Our results should provide new insights into the 
processes of the SGIV-infected cascade and the pathogenesis and replication 
strategies of SGIV. Our SGIV DNA microarrays coupled with global biochemical and 
genetic strategies might greatly accelerate the functional analysis of a number of 
functionally unknown genes in the SGIV genome. Given that most ORFs from GIV, 
as well as a number of ORFs from other iridovirus genomes, such as Ambystoma 
tigrinum virus (Jancovich et al., 2003), Chilo iridescent virus (Jakob et al., 2001), 
Infectious spleen and
 
kidney necrosis virus (He et al., 2001), Lymphocystis disease 
virus 1 (Tidona and Darai, 1997), orange-spotted grouper iridovirus (Lu et al., 2005) 
and tiger frog virus (He et al., 2002), are homologous to those of SGIV (Lu et al., 
2005; Tsai et al., 2005; Song et al., 2004), our results should also be valuable to 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.1. Hierarchical clustering gene tree of SGIV temporal gene expression data. 
Pearson’s correlation coefficient, in which the temporal expression ratios of genes 
were compared pairwise and grouped according to their similarity, were applied to 
cluster the viral genes by using genespring. Each column indicates a time point and 
each row indicates the expression profile of a viral gene. Different colors were used to 
illustrate the different expression level. Green color indicates a low expression level. 
Red color indicates a high expression level. Black color indicates a intermediate 
expression level. The color intensities mean the magnitude of down regulation or up 




Figure 2.2. Validation DNA microarray result with real time RT-PCR. There genes 
(ORF086R, ORF006R and ORF072R) were selected for studies. Gene expression 
level (Y axis) was plotted against time (X axis). The left panel presents the DNA 
microarray data and the right panel presents the real time RT-PCR data. 
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Figure 2.3. Effect of CHX treatment on SGIV gene expression. The vertical axis 
represents the normalized expression level of viral genes in the presence of different 
concentration of CHX with 3PFU/cell SGIV-infection at 2h p.i. and the horizontal 
axis represents the normalized expression level of viral genes with mock SGIV-
infection and different concentration CHX treatment. a). 50µg/ml CHX; b). 100µg/ml 








Figure 2.4.  SGIV gene expression profiles with aphidicoline treatment. Vertical axis 
represents the viral expression level with aphidicoline treatment and 3PFU/cell SGIV-
infection and horizontal axis represents the viral expression level with mock 
aphidicoline treatment and 3PFU/cell SGIV. 
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Table 2.2 SGIV primers 
ORF Forward primer  sense primer 
ORF001L TGACCATGAAGAGTTTCCCGCTGCAA ACCTAACGCGCCACAAGCT 
ORF003R TGACCATGAGCTACGATAGATTCACCATGG GGCCTTGTTCGTCTTGACTGTA 
ORF004L TGACCATGTTACCCATCTTTCTAGCGTCG TGATCTCTTCCCACTACGCTG 
ORF005L TGACCATGTTTGCTTATCGGGTCGGC GCCGACGATGACAAGACCA 
ORF006R TGACCATGAGAGGTAAAAATTCCCATCGTC TTCTTCTTGCTCGTCGTCTG 
ORF007L TGACCATGTGACGATAACTATAAGCCCGG AGGGTATATCTATCGGTTCGGC 
ORF008L TGACCATGAAAGGGCGAAAAGGGACC CCCCTATGGGTCCTTGGTCT 
ORF009L TGACCATGGGCTACAAACGACCCACTG GAGCCAATTCCTGTCCCGT 
ORF010L TGACCATGCTTTTGGTTTCGAGCCCG CCCGAATCGTGGCAACAA 
ORF012L TGACCATGCCGAATGTTTGACCCGAA GAGCGCGGACAAGATGGAT 
ORF014L TGACCATGACTACGGGTTCGATGGCTG CACCCGTTGTCGCAGTTT 
ORF016L TGACCATGCGTTTTAGACGAGTGGCTGAC ATCTCCATGACATTTTCGCG 
ORF018R TGACCATGGTCAGAGACCAAGGCGTTCG CACGTCACATCTGGTCTACACA 
ORF019R TGACCATGAACCCTGACTCTTTGGATTGC TTTAACGTCGTCCATCACCA 
ORF020L TGACCATGTGCTAAACCTCAAGACTCTGGA CTCTTTTGGGGGCTCTGTATTG 
ORF021L TGACCATGTCAATTTGCTCCGCGGAA TACCTAGTCTGCCAAAGTCTGC 
ORF023R TGACCATGACTCTTGCGTCTTGTGGGG GCAATGGACACGCTATGGT 
ORF024L TGACCATGAAATCGGGGAAACCAAACT ATGTCCATATTGTACCAGTCCG 
ORF025L TGACCATGAAACCAAAAGACCTGCAGTGT AAGAGGTCTTCTGGCCAATTGT 
ORF026R TGACCATGGGACATCATGCCAGCAGAG CGTCGGCGTTATATCCTTG 
ORF029L TGACCATGAAACAAAGGCGGGCTCTATA CTCGTTTAGTTTGGGCAGTTT 
ORF030L TGACCATGCAAGCACATGCAAACGTACAC ACGCGTCTGATGTATCTTGTCT 
ORF031L TGACCATGTTCGTGCGAGGGTAGCTACT TCGTTTCGGACAGGTTCG 
ORF033L TGACCATGGGGAATCCGTAACCATAACACA GGTATTTCGTACGCTCTCAGGT 
ORF034L TGACCATGGATCCGAGCGTGTACATTTG TCCGGTATTTTTGTCGATCTGT 
ORF035L TGACCATGAATAAAAAAGACAGCGCCCT TGCAACACATGTATATCAACGG 
ORF036L TGACCATGGGAAAAATAACGTCTCGCTTGA AACTTTCTTGCAGGTATTCTCG 
ORF037L TGACCATGCGTGGTTTACATCGACAGTGAC ATAATGTTTTCCGCGTTTGC 
ORF038L TGACCATGGCAATATAGCCGAAACAGGG CGTTAAGTCCGTTGTTGTTGC 
ORF039L TGACCATGAATGGCGCGGAGATGTTT ATCTATCGATGAGCTGTTGACC 
ORF041L TGACCATGACGGCAGAGAAATTCGCG GACAATCACGCCTCCGGTT 
ORF042R TGACCATGTATTCTAATATGGACCGCGA ATTTTATGCACGGAACGGA 
ORF043R TGACCATGTGGGGCAGCTAAAGGAATT CGTTCTTCGCATACTTTTGA 
ORF045L TGACCATGGCATCCAAACGTAACCTCAGT CCGTCCGCACCCTTTATT 
ORF046L TGACCATGGGACGCGAACGATATAGTGA GAAGTCCTTGAGGGCCTGGT 
ORF047L TGACCATGCTTATTGTCCCGCGTTGG TTATTCGTACGTCCAGCTGC 
ORF048L TGACCATGTGTAGGCATCATCAAACGCA TACTCAAGTTCCATCAAGACGG 
ORF049L TGACCATGTGGCAGTACGTCACGGAATA CATTTTTTTTGCCTAACTCCGG 
ORF050L TGACCATGGAGAAATGCGGCAAAGGTAC CAATATATTGAAGTAGGGGCGC 
ORF051L TGACCATGGGTTATCAGTCCGAATGCGA TAATCCATTTTGCGGTTCTG 
ORF052L TGACCATGTCTTTAGGCAGTTTTACGACGA TTAAACTTGTTCCGCCGC 
ORF054R TGACCATGATAGTGGGCATGTGCATTTTG GCATAAATACCGCGGCAT 
ORF055R TGACCATGCGAGATAAACGGCAGCACT GCCGTCTTTACCCATAGCG 
ORF056R TGACCATGAGCGACGGAACCGAATTA TTAATTTGTAGAGCCTTGAGGG 
ORF057L TGACCATGACGTGTGGACCGAAAAGAAT GCTTATCGTAACCCGCTTTGT 
Continued on following page
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ORF Forward primer  sense primer 
ORF059L TGACCATGCGCCCACCGGTAAATGAGTA TTACAGGTAAGAATGCGCCC 
ORF060R TGACCATGTAGGCTGATGAAAATAAACGGC CCATGAGATCGTTTTCGGA 
ORF061R TGACCATGCAAAGATGTGGTGAAGGCG TCATCGCAAGGTGTAAAAGC 
ORF062R TGACCATGCCACCCAGGAGCCCTCTT GTTCTATGGGGTCTGGCGT 
ORF063L TGACCATGGGGCTCCTGGGTGATATCAT CGGCGGCGAATTGATAGA 
ORF064R TGACCATGTGTACCGTACCGCGTTTGAA GGTCCTGTTTGCTTTGGTTC 
ORF065R TGACCATGTACTGTCTGATATTGAAA TATGATATTTTAGTCGAA 
ORF066R TGACCATGATGACCCCAAAGTTTACGGG TTAGCCGCCGAACGAGTCT 
ORF067L TGACCATGCATTCACGCTAAACTCGACG TCCACAACTTCTTCTTTAGGCG 
ORF068L TGACCATGAAGAAGTGGCGTTTGGACA AGTCCTATTTTCGGTACGTTCG 
ORF069L TGACCATGAATGGAAAACGCGCAGTC TACCGCCATTATTCAGTTGACA 
ORF070R TGACCATGACGAAGCGTGGGAACATTT TGTATCTAATCCGTAAAGGCGT 
ORF071R TGACCATGTAACGGTGAACCAAACAG GAACGTCTACCTCTTTTGT 
ORF072R TGACCATGGGTATTTTTCAGCCTCCATTCC CACTACCAACGCGAACCTCT 
ORF073L TGACCATGTCGGAGAGATGGAACAGTGG TACCTATGGCCTTCAGTTCTTG 
ORF075R TGACCATGGCCACTCGTAAGATCGCCA GCGTATGGAACCGTAACCTT 
ORF076L TGACCATGGTAGGAATGAGCACAGCGC CTCGCCGCGAATTTTCTCTA 
ORF077L TGACCATGAACGAGTACGATTGGGCAA AAGCGAGCGTTGATTTTCC 
ORF078L TGACCATGTCCAAACACGCCAGAACAT GCCCGCGTCAATGAGTTT 
ORF081L TGACCATGCGCTAGATGGTCCGTGAAC GTCTGATCCGTACGCCTGTG 
ORF082L TGACCATGTTTACCCAGGAGCCACGT ACATTCTTCGTCGTCGCC 
ORF083R TGACCATGCAGAGAACCGGTGATGCT GCAATCGTTCCGTTTTCC 
ORF084L TGACCATGGTCCAATACCTCGCAAGCTT GTATGTCTTTTTCGCCACCAAC 
ORF085R TGACCATGCTATTACGAACTATGGTCCGCG AAGACGGTCATGGGTTCG 
ORF086R TGACCATGGATCGGGACGTTCGTTGT GAAAATCGTTGCCCGGTG 
ORF087R TGACCATGACCTGATGGGTATACGTGCAA CTCCGTTATGCGCCCAAT 
ORF088L TGACCATGAGAGTGCAGGGGACGTTGTG TGCAGCTTCTCCAACTTCG 
ORF089L TGACCATGGCCCATGAGTAATTTGTCCAAC TTAATCCATCCTGCGCCT 
ORF090L TGACCATGTGAAAAAGTGGCCGCAGA TACGGTCTTTAAATCCTCGAGC 
ORF091L TGACCATGAAACAAATGTGCTACGCTTCC TGGTTTGCCCACGTTTTGTAC 
ORF092L TGACCATGCAAATATGCTACGCGGAATC TTTGTTTTCGCGCGATAATC 
ORF093L TGACCATGTTATGCCCGAAAACTACGACT AATTTGGTCGTCGTTTGCA 
ORF096R TGACCATGGTATATGAACGCGTGCAC CTCCTATTCTCTACATTTGC 
ORF097L TGACCATGTGATACGAGCGCACGGAAG ACCTAGCGGCTACAAACAGTCT 
ORF098R TGACCATGACCGGGCGAAAGTTTATCA CGTTTGGCGCAGTCTCTT 
ORF099R TGACCATGGACACTGAAAAAGATTGCGTTG CATCTTTCACAATTGGACAACG 
ORF101R TGACCATGACGAAGACAGCTGGGCCAT CGATCTAAAGGTTCCACGACG 
ORF102L TGACCATGAAAACCATCACGATTGACGTC TTACACTCCTCCTCTCAATCGC 
ORF103R TGACCATGAATGCTAGTCATGTATCTCGGG TGAGAAGAGAATGGTTGGGC 
ORF104L TGACCATGAGACCCACGCCTATAGACAGAT CGAAGACGGTTCCTGTTTGTAT 
ORF105R TGACCATGTGTACCCTGTGCCCATTTT AGTAGACAGGATGATGCGCA 
ORF107R TGACCATGCAGAGGGCAACGGGACCT TATTATTCCGGCCGCCACG 
ORF108L TGACCATGGGTGGAGGACTCGGGAGA CCCTGATCCCTACGTTCTCTC 
ORF110L TGACCATGCTATTTTTCTCGCGACCGTAT TACAAGTTAAGATGCAGCTGGC 
ORF111R TGACCATGTAGAAACCATGAACATAGGCGA AGTTTACGGGAGTGCCATTT 
ORF112R TGACCATGAGAAAGGAGAGACGGGGATG CGACGTTTTCTTCTCCTTATGC 
ORF114L TGACCATGGCGACGGCGGTGTATTTT CGCTATGGCTCCGCTTTT 
Continued on following page
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ORF Forward primer  sense primer 
ORF115R TGACCATGTTTCGGACGGCAACTTGA AGCGTTGGTTACCGAAGAGT 
ORF116R TGACCATGTTGACCGATAAAAGAGACGACG CACCCCAAATGATCGTATAGTT 
ORF118R TGACCATGAACGGAAACCCCTCTAGAAAA CGAGGGACAAAACGAAGTAAGT 
ORF119R TGACCATGGTTTTTAACAACGGCTATTCGC TTTGCACCACGGAAGGAT 
ORF120L TGACCATGGTCAAAGCGTTCGCCGTT GAGGTGTCCCATATGGCGT 
ORF121R TGACCATGTGGACTCTTGCACGATATATCA TCGGGTATGGAAAATCTCAGT 
ORF122L TGACCATGGGATACGCTCGCTGCAAA CCATTTTTTCACCAACGCC 
ORF123L TGACCATGCCGAGCGAGTAATAGTGTTTTC TCATAAATTGGCGAACTCGTTG 
ORF124R TGACCATGGTGCCGTGCGTAGGATTT CGTGCCTCCTATAAAAGCGT 
ORF125R TGACCATGCCGTGCGTGGGTATGTGTA CATTGACCTCCTGAGAACGTTC 
ORF126R TGACCATGGGGTGGCCGTGTACAAAT TGAGTATATCCCCACGAGCCT 
ORF127R TGACCATGTGTTCTGCCGAAAATCAATGTC ATCCCCATTTACCTCCGTTA 
ORF128R TGACCATGAGGCTCGAGTATGTGGTCTTAA CCTTTCTGTATGCCACCCTC 
ORF131R TGACCATGGATTTTTCGGCGGTGCTT CAATAAACGGTAAGCGCCA 
ORF132R TGACCATGGAAAAACCGTTTAGGAGCGTAT TGAGATATGCGCCTTGTACTGT 
ORF133R TGACCATGGTATACTGCGAAGGACCTCCC GCGCCTCTTCTTCCATATCG 
ORF134L TGACCATGGGCAAATAAAACTGGATGTGGA CGTTAAAAAATCTGGCGCGT 
ORF135L TGACCATGCGGAGCAACACCACGTCTATA GGTTCCGGCGTCTTCTTT 
ORF136R TGACCATGGGATGAATCAAGAAATGCAGAC GAAAAGGGATGCAGCAACA 
ORF137R TGACCATGGGTATGCCCGATGGAAACT CCCCGCAGTTGAATGGAA 
ORF139R TGACCATGCGTATCAAAACGACAAACTCCA TTTTAAATACTACGCCGCGA 
ORF140R TGACCATGGAAAAAGCTTTAGAGACGGCG TTCTTTTCCGCCTCTTCG 
ORF141R TGACCATGCGTTGGTGATCGCGACTAT GCGAGGTTGTTGGGATAGTAAT 
ORF142L TGACCATGTTCTGGTCCGCCTCTGTTG AAACTGTTGGCACTGGCG 
ORF143L TGACCATGATGGACGAGTTTCTCCGTACTA ACGCCCAAAAAGATACCCAAC 
ORF144R TGACCATGTGTGAGAGCGGGCCAGATA TTCCCGCCTTGTCTATGG 
ORF145R TGACCATGACGTGTGTATGTACTCCGGCG CGGGAGGTAAGGCTTTCTG 
ORF146L TGACCATGGCTGGGAATGCTTGAGAAA GTCGGCAATGTCAACAATCTG 
ORF147L TGACCATGCGTGATGACCGTGAGCAAATT TTACCTTAACCACGATGCGA 
ORF148R TGACCATGTTTACGGTTACGAGGATACACG GCTTCCGAAAGACATACGTGC 
ORF149R TGACCATGCCCTCACAGTGCAAGACAAG TTGTTTCGACGTCGTACCAT 
ORF150L TGACCATGGCGGAGATGCTTGTTCAGAT AATGATTGGCCCTTTCCG 
ORF151L TGACCATGGGGTACGGTGTTGGAAATTATA CTTCAAAAAGCAATTCCACCG 
ORF152R TGACCATGGGATAAGACGGCGTGGTGT CCACCGCGCAGTTTAGAT 
ORF154R TGACCATGGATTTCATCCGTTTCTGGTACA AAGCGCGTCGAAAAGATC 
ORF155R TGACCATGCGACATTTCCGGGTGCAA CGTCTTTCTTCTCCGTTTCGT 
ORF156L TGACCATGTACAATGCCATCTCGCGA CTAATAATTTTTCAGCTGCGCG 
ORF157R TGACCATGAGGCGGCGAAGAATGGTT CGGTTTCCAAAGTATTCGGC 
ORF158L TGACCATGTACGCACCTAAACCACGGG TTAAACGGCCGCCAAAGT 
ORF159R TGACCATGGCCCCGGTCACAAACAAA CATACCTTTTCCTCGCTTGTG 
ORF160L TGACCATGTGCACTACGGTCACATTCGA AGGCACGCTCACAACGAT 
ORF162L TGACCATGAAACGCGTGGTAAAGATGGT TCACTCTTCTTCGTCGGGA 
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Table 2.3. Partial cDNA sequences of β-actin and GAPDH 
Gene name cDNA Sequence 
β-actin GAGAAGAGCT ACGAGCTGCC TGACGGACAG 
GTCATCACCA TCGGCAATGA GAGGTTCCGT 
TGCCCAGAGG CCCTCTTCCA GCCTTCCTTC 
CTCGGTATGG AGTCCTGCGG AATCCACGAG 
ACCACCTACA ACAGCATCAT GAAGTGCGAC 
GTCGACATCC GTAAGGACCT GTACGCCAAC 
ACCGTGCTGT CTGGAGGTAC CACCATGTAC 
CCAGGCATCG CTGACAGGAT GCAAAAGGAG 
ATCACAGCCC TGGCCCCATC CAC 
 
GAPDH GGACACCACC TGGTCCTCGG TGTAACCCAA 
CACTCCCTTC ATGGGCCCAT GTGCGGCCTT 
CTTGCAGGCT TCCTTAATGT CAGCATAAGA 
TGCAGGCTTG GACAGACGGC ATGTCAGGTC 
CACCACTGAC ACATCAGCAA CTGGCACCCT 
GAATGCCATG CCTGTCAGCT TACCGTTGAG 
CTCAGGGATG ACTTTGCCCA CTGCCTTGGC 
GGCACCGGTG GAGGCTGGAA TGATGTTTGT 





Table 2.4. Primers for Real time PCR 
Gene Forward primer Reverse primer 
β-actin TACGAGCTGCCTGACGGACA GGCTGTGATCTCCTTTTGCA 
ORF086R GATCGGGACGTTCGTTGT GAAAATCGTTGCCCGGTG 
ORF006R AGAGGTAAAAATTCCCATCGTC TTCTTCTTGCTCGTCGTCTG 
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3.1 Summary 
Here we report the first proteomics study of grouper embryonic cells (GEC) infected 
by Singapore grouper iridovirus (SGIV). The differential proteomes of GEC with and 
without virus infection were studied and quantitated with iTRAQ labeling followed 
by LC-MS-MS. There are forty nine viral proteins recognized and eleven of them 
were identified for the first time. Moreover, approximately seven hundreds host 
proteins were revealed. In SGIV-infected grouper embryonic cells, fourteen host 
proteins were up-regulated and five host proteins were down-regulated. In this chapter, 
we present a new insight into the interaction of the virus and the host cell at a 
proteome scale. This study might significantly contribute to the understanding of 
infection mechanism and pathogenesis of SGIV. 
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3.2 Introduction 
Recently, Chen and coworkers discovered that 127 ORFs of SGIV were 
transcriptionally active (Chen et al., 2006). Although a total of 51 SGIV proteins were 
identified, the translational products of the remaining 111 ORFs are unknown (Song 
et al., 2004; Song et al., 2006).  
Isobaric Tags for Relative and Absolute Quantification (iTRAQ) can be used for the 
comparison of up to four different samples simultaneously (Ross et al., 2004. ). In this 
study, iTRAQ was used to investigate the quantitative proteomics analysis of SGIV-
infected cells compared to the SGIV mock-infected cells. To our knowledge, this is 
the first proteomics study on iridovirus and host interaction.  
3.3 Materials and methods 
3.3.1 Cell and virus infection 
Protocols for cell and virus infection were described earlier in Chapter 2. 
3.3.2 iTRAQ Labeling and Two Dimensional (2D) LC-MALDI MS 
The mock-infected cells and infected cells (48 hours post infection of SGIV) were 
lysed with lysis buffer (0.5 M triethylammonium bicarbonate, pH 8.5, containing 1 % 
SDS). One hundred micrograms of total proteins from SGIV-infected cell lysate and 
equivalent amount of proteins from mock-infected cell lysate were used for iTRAQ 
experiments. Firstly, the proteins were reduced and cysteines blocked according to the 
iTRAQ kit‘s protocol (Applied Biosystems). Then, the samples were 10X diluted with 
0.5 M triethylammonium bicarbonate, pH 8.5. 25 microliters of a 1 µg/µL trypsin 
(Applied Biosystems) and incubated at 37 °C overnight. The samples were vacuum-
dried and reconstituted with 30 µL 0.5 M triethylammonium bicarbonate, pH 8.5.  The 
proteins from the mock-infected cells were labeled with iTRAQ 114 reagents, and the 
proteins from the SGIV-infected cells were labeled with iTRAQ 115 reagent. After 
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that, the labeled samples were pooled and purified using a strong cation exchange 
(SCX) column (Applied Biosystems). The bound peptides were eluted with 5 % 
NH4OH in 30 % methanol. 
After drying, the iTRAQ-labeled peptides were resuspended with 20 µL 5 mM 
KH2PO4 buffer containing 5 % ACN, pH 3.0, and separated using an Ultimate dual-
gradient LC system (Dionex-LC Packings). At the first dimension separation, we used 
a 0.3 × 150-mm SCX column (FUS-15-CP, Poros 10S, Dionex-LC Packings). The 
mobile phase A and B was 5 mM KH2PO4 buffer, pH 3.0, containing 5 % ACN and 5 
mM KH2PO4 buffer, pH 3.0, containing 5 % ACN and 500 mM KCl, respectively, 
with a flow rate of 6 µL/min. The eluants with step gradients of mobile phase B 
(unbound, 0-5, 5-10, 10-15, 15-20, 20-30, 30-40, 40-50, and 50-100 %) were captured 
alternatively with two 0.3 × 1-mm trap columns (3-µm C18 PepMap, 100 Å, Dionex-
LC Packings) and washed with 0.05 % trifluoroacetic acid (TFA) to remove salts. At 
the second dimension separation, we used a 0.2 × 50-mm reverse-phase column 
(Monolithic PS-DVB, Dionex-LC Packings) by using 2 % ACN with 0.05 % TFA as 
mobile phase A and 80 % ACN with 0.04 % TFA as mobile phase B, respectively, 
with a gradient of 0-60 % mobile phase B in 15 min and a flow rate of 2.7 µL/min. 
The LC fractions were mixed with MALDI matrix solution in a flow rate of 5.4 
µL/min through a 25-nL mixing tee (Upchurch Scientific, Oak Harbor, WA) and 
spotted onto 192-well MALDI target plates (Applied Biosystems) with a Probot 
Micro Fraction collector (Dionex-LC Packings).  
The samples were analyzed by using an ABI 4700 Proteomics Analyzer MALDI 
TOF/TOF mass spectrometer (Applied Biosystems, Foster City, CA). GPS Explorer 
software version 3.5 (Applied Biosystems) employing MASCOT search engine 
(version 2.1; Matrix Science) was used for peptide and protein identification and 
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iTRAQ quantification. The NCBI database was used as the database. Cysteine 
methanethiolation, N-terminal iTRAQ labeling and iTRAQ labeled lysine were 
selected as fixed modifications during iTRAQ data analysis.  
3.3.3 RT PCR  
Total RNA was extracted from infected cell culture at late stage (48 hours post 
infection) using an RNaesy mini kit (QIAGEN). The extracted RNA was treated with 
RNase-free DNase I (QIAGEN). RT-PCR was conducted as described in one step RT 
PCR kit (QIAGEN) protocol using treated RNA and gene specific primers. Briefly, in 
reverse transcription step, cDNA was synthesized from total RNA at 50○C for 30 min. 
The reverse transcriptase was inactivated by a heating step at 95○C for 15 min. The 
PCR amplification of target genes was started after activation of the HotStarTaq DNA 
polymerase. The amplification reactions were carried out for 30 cycles under 
conditions of 95○C for 30s, 55○C for 30s and 72○C for 1.5min per cycle. The RT-PCR 
products then were analyzed with 1.2% agarose gel. 
3.3.4 Western blotting 
Infected cells (48 hour post infection) and mock-infected cells (for mock-infected 
control) were harvested. The cell lysate was treated with 5X SDS loading dye and 
boiled for 10 min. The proteins were separated by SDS-PAGE 15% gel and blotted 
onto a Nitrocellulose membrane (Amersham) in blotting buffer (3.21 g Tris base, 
14.25 g glycine and 200 ml methanol per liter) for 1h at 70V. The blotted membrane 
was then blocked in 5% skim milk, 1% BSA in TBST (20 mM Tris pH 7.4, 154 mM 
NaCl, 0.1% Tween 20) for 1hour, washed 3 × 10 min with TBST. The membranes 
were incubated with the first antibodies (different dilution for different antibodies) for 
1 hour, washed with 3 × 10 min TBST, treated with second antibodies for 1hour: anti-
mouse antibody (Chemicon) or anti-rabbit antibody (Amersham), washed 3 × 10 min. 
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After that, the membranes were treated with a mixture of Super Signal West Pico 
Stable Peroxide Solution and luminol enhancer solution for 5 min and ready for 
exposure to X-ray film and image developing. 
3.4 Results 
3.4.1 Identification of viral proteins by using iTRAQ  
By using iTRAQ, a total of 49 viral proteins were identified. The total ion score 
confidence interval calculation total ion (total ion score C.I. %) of 48 viral proteins is 
larger than 95% (Table 3.1. & Table 3.2). Only ORF022L, which has been reported 
previously, showed a total ion score C.I. % of 86.351%. A total of 38 viral proteins 
have been reported earlier (Song et al., 2004; Song et al., 2006), and these proteins 
are listed in Table 3.1. The remaining 11 viral proteins identified from iTRAQ all 
showed a total ion score C.I. % >95% and were first reported in this study. These 11 
newly identified viral proteins are listed in Table 3.2. Among these 11 newly 
identified viral proteins, only ORF049L was predicted to a dUTPase-like protein. The 
other 10 proteins are functionally unknown and are considered as novel proteins. 
Given that 162 open reading frames was predicted from the SGIV genome, only 49 
viral proteins were identified by iTRAQ. The reasons for this phenomenon could be: 1) 
not all 162 open reading frames have translational products in cell culture; 2) iTRAQ 
is not sensitive enough to identify the low abundant proteins; 3) some of viral proteins 
might be expressed at a different stage of viral infection.  
3.4.2 Identification of differential expression host proteins by using iTRAQ 
Given the unknown nature of the grouper Epinephelus tauvina genome, when we 
analyzed the iTRAQ data against NCBI, only 743 host proteins were identified (Table 
3.5). Among these host proteins, only 726 host protein showed a total icon score C.I. 
% >95% (Table 3.5).  When we compared the SGIV-infected GECs (iTRAQ 115 
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labeled) to the mock SGIV-infected GECs (iTRAQ 114 labeled), 12 host proteins 
(total icon score C.I. % >95%) were >1.5 fold up-regulated, and 5 host proteins (total 
icon score C.I. % >95%) were >1.5 fold down-regulated (Table 3.3. & Table 3.4.). 
Among the up-regulated host proteins, ATP synthase F1 alpha subunit in ATP 
synthesis coupled proton transport; dihydrofolate synthase in folic acid and derivative 
biosynthetic process (Tettelin et al., 2005); mucin-associated surface protein in the 
innate immune system; alpha-2-macroglobulin isoform 1 is involved in protease 
inhibition; transposase is an enzyme that binds to single-stranded DNA and can 
incorporate it into genomic DNA. In the down-regulated proteins, Chain A Rotamer 
Strain As A Determinant Of Protein Structural Specificity and ribosomal protein S27a 
are involved in ubiquitination; histone H3 plays critical roles in genomic DNA 
packaging and gene transcriptional regulation; Rho GTPase is involved in complex 
mechanical processes such as cell motility and phagocytosis (Wherlock and Mellor, 
2002). Given that two up-regulated proteins, Matrix protein and putative head-tail 
adaptor, do not match to any of the 162 ORFs from the SGIV genome, we classified 
them into host proteins.   
3.4.3 RT-PCR and western blot analysis of the viral proteins 
The transcriptsomes of the 11 newly identified proteins were characterized by using 
RT-PCR (Table 3.6). Figure 3.1 shows that these 11 new viral proteins have full 
length transcriptional products. The transcriptional products of the other 38 viral 
proteins have been reported (Song et al., 2004; Song et al., 2006). We generated 
specific antibodies against 5 viral proteins (i.e. ORF018R, ORF026R, ORF093L, 
ORF135L, and ORF140R) by using the purified recombinant viral expressed in E. 
coli. The full length protein products for ORF018R, ORF026R, and ORF093L have 
not been reported before. Here, by using specific antibodies, we demonstrate that 
 52 
ORF018R, ORF026R and ORF093L encode full length proteins. In addition, we 
further demonstrated that the two newly identified viral proteins, ORF135L and 
ORF140R, code for two full length viral proteins.  
3.4.4 Up regulation of host Histone H3 Lysine 79 (K79) methylation upon SGIV 
infection 
iTRAQ data showed that host histone H3 was down-regulated upon SGIV infection 
(Table 3.4). To validate this finding, we carried out western blot against histone H3 
by using the commercial polyclonal antibodies against histone H3. We were surprised 
to find that total histone H3 was not down-regulated upon SGIV-infection (Data not 
shown). Because we did not include any kinds of post translational modification when 
we analyzed the iTRAQ data, the iTRAQ data only showed that the non modified 
form of histone H3 was down-regulated upon SGIV infection. Given that total histone 
H3 did not change upon SGIV infection, we postulated that the modified form of 
histone H3 might be up-regulated. Histone H3 can undergo many kinds of post 
translational modifications, such as methylation, acetylation, and phosphorylation 
(Zhang and Reinberg, 2001; Lacoste et al., 2003; Li et al., 2007). In order to figure 
out what kind of modifications that could account for the findings presented above, 
we reexamined the iTRAQ raw data, and found that the peptide “EIAQDFKTDLR” 
of histone H3 was the only peptide identified from iTRAQ analysis and the non-
modified form of this histone H3 peptide showed down regulation upon SGIV 
infection. This histone H3 peptide sequence “EIAQDFKTDLR” contains a lysine 
residue (i.e. K), which is referred as K79 in histone H3, and K79 can undergo 
methylations. We proposed that the K79 methylation form of histone H3 could be up-
regulated. Combination of the up regulation of the K79 methylated form of histone 
H3 and the down-regulation of the K79 non-methylated histone H3 would make the 
 53 
total histone H3 unchanged. To test this hypothesis, we carried out western blots 
against K79 methylated histone H3 by using the specific polyclonal antibodies against 
the K79 methylated form of histone H3. The results are shown in Figure 3. The first 
panel shows that the K79 methylated form of histone H3 was up-regulated upon 
SGIV infection; the middle panel shows that the total histone H3 was not changed 
upon SGIV infection; the bottom panel shows that the beta actins, which were used as 
controls, were not changed (Figure 3.3). By combining the iTRAQ and western blot 
data, we conclude that upon SGIV infection, the host histone H3 K79 methylation is 
up-regulated, and the total host histone H3 is not changed. 
3.5 Discussion 
In this study, for the first time, we have examined the infection of SGIV with host cell 
at proteome scale by using iTRAQ. We have identified 49 SGIV viral proteins (Table 
3.1 & Table 3.2). Eleven out of the 49 viral proteins were first reported (Table 3.1). 
The transcriptional products for these 11 viral ORFs were validated by RT-PCR 
(Figure 3.1). Two newly identified viral proteins, ORF135L and ORF140R, were also 
validated by western blot (Figure 3.2). In addition, the translational products of 
another three viral proteins, ORF018R, ORF026R, and ORF093L, were confirmed by 
western blot (Figure 3.2). Among the 49 SGIV viral proteins, only 6 viral proteins are 
predicted to share homologies with known functional proteins: ORF049L coded the 
dUTPase-like proteins, ORF072R for the major capsid proteins, ORF081L, the 
tyrosine kinase-like proteins, ORF084L, the RNase III like proteins, ORF086R, the 
putative immediate-early proteins, and ORF102L, the ubiqutin/ribosomal protein like 
proteins. The remaining 43 viral proteins are all functionally unknown. Our studies 
identified that these viral proteins were real viral coding proteins. These results would 
be valuable for the functional studies of these viral proteins.  
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The proteomics scale analysis of SGIV-infected GECs by iTRAQ also provides 
important insight into the SGIV and host cell interactions by providing information on 
the differential expression of host proteins. These differential expressions of host 
proteins are involved in multi cellular processes, and are closely linked together to 
form a complex host response to SGIV infection. The dihydrofolate synthase, which 
is involved in the folic acid biosynthetic process, was up-regulated (Tettelin et al., 
2005). The up regulation of dihydrofolate synthase may lead to the up regulation of 
folic acid that is needed to replicate DNA (Jennings, 1995), and the folic acid 
biosynthetic process needs ATPs as an energy source. It is not surprising to find that 
the ATP synthase F1 alpha subunit, which is involved in ATP synthesis, was also up-
regulated in SGIV-infected GECs. The up regulation of dihydrofolate synthase and 
ATP synthase F1 alpha subunit may play important roles in the replication of SGIV 
genomic DNA in the host cells. When the host cells were infected by SGIV, host 
mucin-associated surface protein, which is involved in the innate immune regulation, 
and Rho GTPase, which is involved in complex mechanical processes such as cell 
motility and phagocytosis, was up-regulated. This phenomenon may account for the 
regulation of the host immune responses, when SGIV infects host cells. In addition, 
the up-regulated of alpha-2-macroglobulin isoform 1, which is involved in protease 
inhibition, could play roles in the protection of newly synthesized viral proteins 
during SGIV replication inside host cells. The up regulation of transposase, which is 
involved in the incorporation of DNA fragments into genomic DNA, could play 
important role in integrating SGIV genomic DNA into host genome. We also found 
that two proteins, Chain A Rotamer Strain As A Determinant Of Protein Structural 
Specificity and ribosomal protein S27a, which are involved in ubiquitination process, 
were down-regulated upon SGIV infection. Given that SGIV genome contains an 
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open reading frame coding the ubiquitin like protein, the down regulation of host 
unbiquitination related proteins could play very important role in the regulation of 
host protein degradation.  
Another interesting finding is that the K79 methylation of histone H3 was up-
regulated during SGIV infection (Figure 3.3). Histone H3 plays an very important role 
in genomic package. Histone H3 together with H2A, H2B, and H4, assembles to form 
one octameric nucleosome core particle by wrapping 146 base pairs of DNA around 
the protein spool in 1.65 left-handed super-helical turn (Luger et al., 1997). Histones 
are subjected to an enormous number of posttranslational modifications, including 
acetylation and methylation of lysines (K) and arginines (R), phosphorylation of 
serines (S) and threonines (T), ubiquitylation and sumoylation of lysines, as well as 
ribosylation (Peterson and Laniel, 2004). Since chromatin is used as the physiological 
template for all DNA-mediated processes, histone modifications play very important 
roles in controlling the structure and/or function of the chromatin fiber, and different 
modifications can yield distinct functional consequences. For histone H3, the 
posttranslational modification could be the acetylation of lysines (K), methylation of 
lysines (K) and arginines (R), and phosphorylation of serines (S) and threonines (T). 
The acetylation of histone H3 could happen at K4, K9, K14, K18, K23, and K27. K4, 
K9 and K27 can also be subjected to methylation. Besides K4, K9 and K27, 
methylation of histone H3 can also happen at R27, K36 and K79. Besides acetylating 
and methylation, histone H3 can also be subjected to phosphorylations. The 
phosphorylation of histone H3 can occur at T3, S10, T11, and S28. In addition, the 
different modifications of histone H3 may lead to different functional consequences. 
Histone H3 lysine methylations are closely related to the gene silencing and gene 
activations. It has been reported that G9a/GLP-mediated H3-K9 methylation functions 
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in the silencing of individual genes (Tachibana et al., 2005). Besides H3-K9 
methylation, the methylation of histone H3 K27 has been reported to be linked to 
several silencing phenomena including homeotic-gene silencing, X inactivation and 
genomic imprinting (Cao and Zhang, 2004). However, the methylations on the sites of 
histone H3 K4, K36 and K79 are associated with gene activations (Martin and Zhang, 
2005). Compared to histone H3 K4 methylation, the functions of histone H3 K36 and 
K79 methylation are not well defined (Martin and Zhang, 2005). Recent study showed 
that histone H3 K79 methylation could be involved in DNA repair (Huyen et al., 
2004). Additionally, histone H3 K79 methylation was also reported to be involved in 
leukemic transformation (Okada et al., 2005). Our results showed that histone H3 
K79 methylation was up-regulated when host cells were infected by virus. Given that 
little is known about the function of histone H3 K79 methylation, our finding may 







    
Figure 3.1 Full length amplification of 11 novel genes of SGIV via RT-PCR. Total 
RNA (harvested after 48h of infection) was isolated by using the One Step RT-PCR 





      
 
Figure 3.2 Presence of SGIV proteins expressed by ORF018R, 026R, 093L and 2 







Figure 3.3 Histone H3 K79 methylation analysis of SGIV-infected GECs compared to 
mock SGIV-infected GECs by western blot. Left lane represents the sample from the 
mock SGIV-infected GEC. Right lane represents the sample from the SGIV-infected 
GEC. First panel represents K79 methylated form of histone H3. Middle panel 
represents histone H3. Bottom panel represents the beta actin.  
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Table 3.5. GEC host proteins identified from iTRAQ analysis 
Protein  
Name 
 Chain  , Modified Beta Trypsin (Monoisopropylphosphoryl Inhibited) (E.C.3.4.21.4) 
(Neutron Data) 
 Chain  , Structure Of Hydrolase (Serine Proteinase) 
[Segment 3 of 4] Pollen allergen Sal k 1 
14-3-3 epsilon2 isoform [Schistosoma bovis] 
14-3-3.a protein [Fundulus heteroclitus] 
26S proteasome regulatory subunit S4 like AAA ATpase [Cryptosporidium parvum Iowa II] 
3-deoxy-7-phosphoheptulonate synthase [Lactococcus lactis subsp. lactis Il1403] 
3-deoxy-7-phosphoheptulonate synthase [Planctomyces maris DSM 8797] 
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) [Danio rerio] 
3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 
[Danio rerio] 
40S ribosomal protein S11 [Stizostedion vitreum] 
40S ribosomal protein S12 
40S ribosomal protein S13 
40S ribosomal protein S16 
40S ribosomal protein S18 
40S ribosomal protein S19 
40S ribosomal protein S3a 
40S ribosomal protein S3a [Siniperca chuatsi] 
40S ribosomal protein S6 
40S ribosomal protein S6 [Pseudopleuronectes americanus] 
40S ribosomal protein S7 
40S ribosomal protein S8 
40S ribosomal protein Sa-like protein [Sparus aurata] 
40S ribosomal small subunit protein S10 [Xenopus laevis] 
4SNc-Tudor domain protein short form [Danio rerio] 
50S ribosomal protein L22 [Flavobacterium sp. MED217] 
60S acidic ribosomal protein P1 [Platichthys flesus] 
60S ribosomal protein L10a 
60S ribosomal protein L18 
60S ribosomal protein L22 [Scophthalmus maximus] 
60S ribosomal protein L23 [Ustilago maydis 521] 
60S ribosomal protein L28 (L29) (YL24) (RP44) (L27a) (RP62) 
60S ribosomal protein L31 
60S ribosomal protein L34 
60S ribosomal protein L35 [Scophthalmus maximus] 
60S ribosomal protein L6 [Pagrus major] 
60S ribosomal protein L7a 
60S ribosomal protein L8 
ABC-type transport system, ATPase component [Uncultured methanogenic archaeon RC-
I] 
ABR117Cp [Ashbya gossypii ATCC 10895] 
acetylcholinesterase - rabbit 
acetyl-CoA C-acyltransferase [Pyrobaculum aerophilum str. IM2] 
acidic ribosomal phosphoprotein P0 [Mus musculus] 
actin [Aspergillus nidulans FGSC A4] 
actin [Gossypium hirsutum] 
actin [Gregarina polymorpha] 
actin [Haemaphysalis longicornis] 
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actin [Haliotis rufescens] 
actin [Japetella diaphana] 
actin [Kluyveromyces polysporus] 
actin [Leucocryptos marina] 
actin [Mastigoteuthis magna] 
actin [Micronuclearia podoventralis] 
actin [Monodonta perplexa perplexa] 
actin [Nuclearia simplex] 
actin [Oxystele tigrina] 
actin [Panax ginseng] 
actin [Phaseolus acutifolius] 
actin [Phoma nigrificans] 
actin [Pterosperma cristatum] 
actin [Saccharomyces kunashirensis] 
actin [Saccharomyces spencerorum] 
actin [Symbiodinium sp. clade C] 
actin 1 [Paxillus involutus] 
actin 2 [Strongylocentrotus purpuratus] 
actin 5 [Aedes aegypti] 
actin related protein 2/3 complex subunit 2 [Homo sapiens] 
Actin, muscle 
actinin, alpha 3 [Homo sapiens] 
actinin, alpha 3 [Xenopus laevis] 
actin-like protein [Homo sapiens] 
actin-related protein - Japanese pufferfish 
acyl carrier protein (ACP) [Pseudomonas entomophila L48] 
adenine nucleotide translocator s254 [Takifugu rubripes] 
adenosylhomocysteinase [Solibacter usitatus Ellin6076] 
adenylate kinase [Nitrobacter winogradskyi Nb-255] 
alanyl-tRNA synthetase [Danio rerio] 
Aldehyde dehydrogenase [Caulobacter sp. K31] 
aldolase c, fructose-bisphosphate [Danio rerio] 
alpha actinin 4 [Homo sapiens] 
alpha tropomyosin [Gillichthys mirabilis] 
alpha tubulin [Gillichthys mirabilis] 
alpha tubulin [Notothenia coriiceps] 
alpha tubulin 1 [Rhynchopus sp. ATCC 50230] 
Alpha-actinin-2 (Alpha actinin skeletal muscle isoform 2) (F-actin cross-linking protein) 
Alpha-enolase (2-phospho-D-glycerate hydro-lyase) (Non-neural enolase) (NNE) (Enolase 
1) 
alpha-internexin 
alpha-tubulin [Bombyx mori] 
alpha-tubulin [Dicyema japonicum] 
alpha-tubulin [Jakoba incarcerata] 
alpha-tubulin [Medicago truncatula] 
alpha-tubulin [Spathidium sp.] 
alpha-tubulin [Strobilidium sp.] 
alpha-tubulin [Vorticella microstoma] 
alpha-tubulin 2 [Homarus gammarus] 
annexin 11a isoform 2 [Danio rerio] 
annexin A2 [Monopterus albus] 
annexin max3 [Oryzias latipes] 
annexin max3 [Pagrus major] 
Asparagine synthetase [glutamine-hydrolyzing] (Glutamine-dependent asparagine 
synthetase) (Cell cyc 
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aspartate-tRNA ligase [Cryptococcus neoformans var. neoformans JEC21] 
ATCXXS1 (C-TERMINAL CYSTEINE RESIDUE IS CHANGED TO A SERINE 1); thiol-
disulfide exchange intermedia 
ATP synthase alpha-subunit [Ciona intestinalis] 
ATP synthase beta chain, mitochondrial precursor, putative [Plasmodium falciparum 3D7] 
ATP synthase beta chain, mitochondrial, putative [Arabidopsis thaliana] 
ATP synthase beta subunit [Pachysandra procumbens] 
ATP synthase F1 subunit alpha [Reclinomonas americana] 
ATP synthase F1, alpha subunit [Crocosphaera watsonii WH 8501] 
ATP synthase F1, beta subunit [Frankia sp. EAN1pec] 
ATP synthase subunit B [Brucella melitensis 16M] 
ATP synthase subunit B [Mycoplasma hyopneumoniae 232] 
ATP synthase subunit B [Mycoplasma mycoides subsp. mycoides SC str. PG1] 
atpase 
ATPase associated with various cellular activities, AAA_5 [Nocardioides sp. JS614] 
ATPase, AAA family protein [Tetrahymena thermophila SB210] 
AtRABA1e (Arabidopsis Rab GTPase homolog A1e); GTP binding [Arabidopsis thaliana] 
beta actin [Atherina boyeri] 
beta tubulin [Apusomonas proboscidea] 
beta tubulin [Culex pipiens pipiens] 
beta tubulin [Gillichthys mirabilis] 
beta tubulin [Glomus claroideum] 
beta tubulin [Glomus sp. BEG19] 
beta-2 tubulin [Aedes aegypti] 
beta-2 tubulin [Gadus morhua] 
beta-actin [Macrobrachium rosenbergii] 
beta-actin [Monopterus albus] 
beta-actin [Mustela putorius furo] 
beta-actin [Pomacentrus moluccensis] 
beta-actin [Vanessa cardui] 
beta-tubulin [Basidiobolus microsporus] 
beta-tubulin [Bombyx mori] 
beta-tubulin [Bombyx mori] 
beta-tubulin [Bombyx mori] 
beta-tubulin [Chaetosphaeria chlorotunicata] 
beta-tubulin [Crassostrea gigas] 
beta-tubulin [Dicyema japonicum] 
beta-tubulin [Esslingeriana idahoensis] 
beta-tubulin [Halocynthia roretzi] 
beta-tubulin [Microbotryum violaceum] 
beta-tubulin [Monosiga brevicollis] 
beta-tubulin [Phytophthora palmivora] 
beta-tubulin [Schistosoma haematobium] 
beta-tubulin [Schistosoma japonicum] 
beta-tubulin [Sclerospora graminicola] 
biliverdin reductase B (flavin reductase (NADPH)) [Mus musculus] 
BiP, heat shock protein 3 
Branched-chain amino acid aminotransferase II [Xylella fastidiosa Dixon] 
calcyclin-associated protein, CAP50=Ca2+/phospholipid-binding protein L-14 fragment 
[rabbits, lung, 
calmodulin 
calmodulin [Gonothyraea loveni] 
calmodulin [Homo sapiens] 
calreticulin [Paralichthys olivaceus] 
capping protein (actin filament) muscle Z-line, alpha 2 [Mus musculus] 
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capping protein (actin filament) muscle Z-line, alpha 2 [Takifugu rubripes] 
carboxyl-terminal processing protease [Prochlorococcus marinus str. MIT 9211] 
cation transport ATPase, HAD family [Methanobrevibacter smithii ATCC 35061] 
cation transporter p-type ATPase a CtpA [Mycobacterium ulcerans Agy99] 
CCTgamma 
CG5384-PA [Drosophila melanogaster] 
CG8036-PB, isoform B [Drosophila melanogaster] 
Chain A, Beta-Actin-Profilin Complex 
Chain A, Complex Between Rabbit Muscle Alpha-Actin: Human Gelsolin Domain 1 
Chain A, Crystal Structure Of Bovine Liver Glutamate Dehydrogenase Complexed With 
Gtp, Nadh, And L- 
Chain A, Crystal Structure Of The D3b Subcomplex Of The Human Core Snrnp Domain At 
2.0a Resolution 
Chain A, Crystal Structure Of Two D-Glyceraldehyde-3-Phosphate Dehydrogenase 
Complexes: A Case Of A 
Chain A, Rotamer Strain As A Determinant Of Protein Structural Specificity 
Chain A, Structure Of Hyper-Vil-Trypsin 
Chain A, Structure Of The Dead Domain Of Human Eukaryotic Initiation Factor 4a, Eif4a 
Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With Ser (D189s) 
Chain B, Tubulin Alpha-Beta Dimer, Electron Diffraction 
chaperone protein DnaJ [Geobacter lovleyi SZ] 
chaperone protein DnaK [Shewanella amazonensis SB2B] 
chaperonin [Mesobuthus gibbosus] 
chaperonin [Mesobuthus gibbosus] 
chaperonin containing TCP1, subunit 2 (beta) [Danio rerio] 
chaperonin containing TCP1, subunit 4 (delta) [Homo sapiens] 
chaperonin containing TCP1, subunit 8 (theta) [Homo sapiens] 
chaperonin containing TCP1, subunit 8 (theta) [Xenopus tropicalis] 
chaperonin GroEL , truncated [Syntrophus aciditrophicus SB] 
chaperonin GroEL [Myxococcus xanthus DK 1622] 
chaperonin subunit 6a (zeta) [Mus musculus] 
chaperonin subunit 7 [Pagrus major] 
COG0366: Glycosidases [Bacillus anthracis str. A2012] 
conserved hypothetical protein [Coccidioides immitis RS] 
conserved hypothetical protein [Gibberella zeae PH-1] 
conserved hypothetical protein [Stigmatella aurantiaca DW4/3-1] 
conserved hypothetical protein TIGR00157 [Methylococcus capsulatus str. Bath] 
core-binding factor, beta subunit isoform 2 [Homo sapiens] 
CypA protein [Xenopus laevis] 
cytoplasmic actin CyII [Heliocidaris erythrogramma] 
cytoskeletal actin IIIa [Strongylocentrotus purpuratus] 
cytosolic heat shock protein 70 [Trimastix marina] 
cytosolic malate dehydrogenase A [Oryzias latipes] 
cytosolic malate dehydrogenase thermostable form [Sphyraena idiastes] 
dihydrofolate synthase [Streptococcus agalactiae 18RS21] 
Dihydrolipoyl dehydrogenase, mitochondrial precursor (Dihydrolipoamide dehydrogenase) 
(Glycine clea 
DNA excision repair protein Rad2 [Neosartorya fischeri NRRL 181] 
DNA polymerase 
dnak protein BiP [Tetrahymena thermophila SB210] 
dnaK-type molecular chaperone hsc74 - yeast (Pichia angusta) (fragments) 
elongation factor 1 alpha [Euzercon latum] 
elongation factor 1a [Antonina graminis] 
Elongation factor 1-alpha (EF-1-alpha) 
elongation factor 1-alpha [Rhincalanus nasutus] 
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Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) 
elongation factor 2 [Halichondria sp. AR-2003] 
elongation factor 2 [Nematostella vectensis] 
elongation factor-1 alpha [Micromegistus bakeri] 
elongation factor-1 alpha [Ostrinia nubilalis] 
elongation factor-2 [Echiniscus viridissimus] 
enolase 1, (alpha) [Danio rerio] 
Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial [Bos taurus] 
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial [Mus musculus] 
ENSANGP00000010754 [Anopheles gambiae str. PEST] 
ENSANGP00000012302 [Anopheles gambiae str. PEST] 
ENSANGP00000021214 [Anopheles gambiae str. PEST] 
ENSANGP00000024287 [Anopheles gambiae str. PEST] 
eukaryotic translation elongation factor 2 [Mus musculus] 
eukaryotic translation elongation factor 2 [Rana sylvatica] 
Eukaryotic translation elongation factor 2, like [Danio rerio] 
eukaryotic translation initiation factor 2, subunit 1 alpha [Rattus norvegicus] 
Eukaryotic translation initiation factor 3 subunit 7 (eIF-3 zeta) (eIF3 p66) (eIF3d) 
eukaryotic translation initiation factor 3, subunit 3 (gamma) [Danio rerio] 
eukaryotic translation initiation factor 3, subunit 3 gamma, 40kDa [Homo sapiens] 
eukaryotic translation initiation factor 4A2 [Mus musculus] 
ezrin/radixin/moesin (ERM)-like protein [Ciona intestinalis] 
F1-ATPase beta subunit=H(+)-transporting ATPase beta subunit  [cattle, heart, Peptide 
Mitochondrial Partial, 19 aa] 
fatty acid binding protein 7, brain, a [Danio rerio] 
Fe-S protein assembly chaperone HscA [Polaromonas naphthalenivorans CJ2] 
Fe-S protein assembly chaperone HscA [Stigmatella aurantiaca DW4/3-1] 
fibrillarin [Danio rerio] 
Fibrillarin CG9888-PA [Drosophila melanogaster] 
Filamin-B (FLN-B) (Beta-filamin) (Actin-binding-like protein) (ABP-280-like protein) 
flagellar protein FlaG protein [Shewanella sp. W3-18-1] 
flightless I homolog [Homo sapiens] 
formyl transferase domain protein [Campylobacter jejuni RM1221] 
fructose bisphosphate aldolase [Polypterus senegalus] 
fructose-bisphosphate aldolase A-2 [Acipenser baerii] 
Fructose-bisphosphate aldolase C (Brain-type aldolase) 
Fructose-bisphosphate aldolase, non-muscle type 
fubp1 [Xenopus tropicalis] 
GA10751-PA [Drosophila pseudoobscura] 
gamma actin-like protein [Mus musculus] 
Genome polyprotein [Contains: Coat protein (CP)] 
glucosamine-6-phosphate deaminase [Cytophaga hutchinsonii ATCC 33406] 
glucose regulated protein, 58kDa [Xenopus laevis] 
glucose-regulated protein 78 [Paralichthys olivaceus] 
glucose-regulated protein 78, putative [Leishmania major] 
glucose-regulated protein 94 [Paralichthys olivaceus] 
glutamate oxaloacetate transaminase 2, mitochondrial [Mus musculus] 
glutathione S-transferase [Micropterus salmoides] 
glyceraldehyde-3-phosphate dehydrogenase [Oncorhynchus tshawytscha] 
glyceraldehyde-3-phosphate dehydrogenase, type I [Flavobacteria bacterium BAL38] 
Glycine dehydrogenase subunit [Geobacillus thermodenitrificans NG80-2] 
GTPase ObgE [Caminibacter mediatlanticus TB-2] 
GTP-binding nuclear protein Ran (GTPase Ran) 
GTP-binding protein LepA [Tropheryma whipplei TW08/27] 
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guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 [Danio rerio] 
H2A histone family, member Z [Homo sapiens] 
hCG1642531 [Homo sapiens] 
heart-type fatty acid-binding protein [Fundulus heteroclitus] 
heat shock 60 kD protein 1 [Danio rerio] 
heat shock 60kDa protein 1 (chaperonin) [Gallus gallus] 
Heat shock 70 kDa protein cognate 4 (Hsc 70-4) 
heat shock cognate 70 [Rhynchosciara americana] 
heat shock cognate 70 [Xiphophorus hellerii] 
heat shock cognate 70 kDa protein [Pimephales promelas] 
heat shock cognate 70 protein [Spodoptera frugiperda] 
heat shock protein [Numida meleagris] 
Heat shock protein [Plasmodium berghei strain ANKA] 
heat shock protein 10 [Monopterus albus] 
heat shock protein 60 [Trichinella spiralis] 
heat shock protein 60 kDa [Paralichthys olivaceus] 
heat shock protein 70 [Anatolica polita borealis] 
heat shock protein 70 [Bombyx mori] 
heat shock protein 70 [Capsaspora owczarzaki] 
heat shock protein 70 [Cryptosporidium andersoni] 
heat shock protein 70 [Cyclospora cercopitheci] 
heat shock protein 70 [Euplotes aediculatus] 
heat shock protein 70 [Geodia cydonium] 
heat shock protein 70 [Laternula elliptica] 
heat shock protein 70 [Latimeria chalumnae] 
heat shock protein 70 [Lucilia cuprina] 
heat shock protein 70 [Mizuhopecten yessoensis] 
heat shock protein 70 [Omphisa fuscidentalis] 
heat shock protein 70 [Oxytricha sp. LPJ-2005] 
heat shock protein 70 [Paralichthys olivaceus] 
heat shock protein 70 [Spumella uniguttata] 
heat shock protein 70 isoform 3 [Oryzias latipes] 
heat shock protein 70 isoform 5 [Oryzias latipes] 
heat shock protein 70 precursor [Neocallimastix patriciarum] 
heat shock protein 70, hsp70A2 
heat shock protein 70-B cytosolic isoform [Bodo saltans] 
heat shock protein 70kDa [Pholcus phalangioides] 
heat shock protein 9 [Mus musculus] 
heat shock protein 90 
heat shock protein 90 [Bufo gargarizans] 
heat shock protein 90 beta [Paralichthys olivaceus] 
Heat shock protein DnaJ-like protein [Lentisphaera araneosa HTCC2155] 
Heat shock protein Hsp70 [Xylella fastidiosa Dixon] 
heat shock protein, Hsp70 [Cryptosporidium parvum Iowa II] 
heat-shock protein [Littorina plena] 
heat-shock protein Hsp70 [Oopsacas minuta] 
heat-shock protein Hsp70 [Petrosia ficiformis] 
heavy metal translocating P-type ATPase [Caldicellulosiruptor saccharolyticus DSM 8903] 
hexokinase 1 [Danio rerio] 
high density lipoprotein-binding protein (vigilin) [Danio rerio] 
histone 3 [Frankliniella sp. KY-2004] 
Histone H2A 
histone h2a variant [Cryptococcus neoformans var. neoformans JEC21] 
histone H2B (ISS) [Ostreococcus tauri] 
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histone H2B [Anacropora matthai] 
Histone H2B 1.2 (H2B1.2) 
histone H3 [Anelosimus eximius] 
histone H4 
histone H4 [Cucumis sativus] 
host actin-1 [Rhodomonas chrysoidea] 
HSC71 [Rivulus marmoratus] 
HSP60 [Carassius auratus] 
HSP70 [Chlamys farreri] 
Hsp70 [Hydrogenobacter hydrogenophilus] 
HSP70 [Oxyuranus scutellatus scutellatus] 
Hsp70 protein [Cetorhinus maximus] 
Hsp70 protein [Odontaspis ferox] 
Hsp70Bbb CG5834-PA [Drosophila melanogaster] 
hypothetical protein [Ictalurus punctatus] 
hypothetical protein [Neurospora crassa OR74A] 
hypothetical protein [Paramecium tetraurelia] 
hypothetical protein [Paramecium tetraurelia] 
hypothetical protein [Paramecium tetraurelia] 
hypothetical protein [Paramecium tetraurelia] 
hypothetical protein [Vitis vinifera] 
hypothetical protein [Vitis vinifera] 
hypothetical protein [Vitis vinifera] 
hypothetical protein A - mouse (fragment) 
hypothetical protein Aave_1075 [Acidovorax avenae subsp. citrulli AAC00-1] 
hypothetical protein An07g09990 [Aspergillus niger] 
hypothetical protein BA3462 [Bacillus anthracis str. Ames] 
Hypothetical protein CBG03435 [Caenorhabditis briggsae] 
Hypothetical protein CBG06421 [Caenorhabditis briggsae] 
Hypothetical protein CBG18934 [Caenorhabditis briggsae] 
hypothetical protein CdifQ_04001593 [Clostridium difficile QCD-32g58] 
hypothetical protein CHGG_03067 [Chaetomium globosum CBS 148.51] 
hypothetical protein Chro.80400 [Cryptosporidium hominis TU502] 
hypothetical protein CNBC3800 [Cryptococcus neoformans var. neoformans B-3501A] 
hypothetical protein CNBG1220 [Cryptococcus neoformans var. neoformans B-3501A] 
hypothetical protein DR_1619 [Deinococcus radiodurans R1] 
hypothetical protein FG03504.1 [Gibberella zeae PH-1] 
hypothetical protein GLP_456_20463_41396 [Giardia lamblia ATCC 50803] 
hypothetical protein GTNG_2000 [Geobacillus thermodenitrificans NG80-2] 
hypothetical protein lmo2611 [Listeria monocytogenes EGD-e] 
hypothetical protein LOC335798 [Danio rerio] 
hypothetical protein LOC337595 [Danio rerio] 
hypothetical protein LOC393186 [Danio rerio] 
hypothetical protein LOC394635 [Xenopus tropicalis] 
hypothetical protein LOC432005 [Xenopus laevis] 
hypothetical protein LOC436741 [Danio rerio] 
hypothetical protein LOC436954 [Danio rerio] 
hypothetical protein LOC449552 [Danio rerio] 
hypothetical protein LOC494995 [Xenopus laevis] 
hypothetical protein LOC495253 [Xenopus laevis] 
hypothetical protein LOC496627 [Xenopus tropicalis] 
hypothetical protein LOC548683 [Xenopus tropicalis] 
hypothetical protein LOC550333 [Danio rerio] 
hypothetical protein LOC641421 [Danio rerio] 
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hypothetical protein LOC734647 [Xenopus laevis] 
hypothetical protein LOC767746 [Danio rerio] 
hypothetical protein LOC779096 [Xenopus laevis] 
hypothetical protein MGG_05095 [Magnaporthe grisea 70-15] 
hypothetical protein MtrDRAFT_AC149032g20v2 [Medicago truncatula] 
hypothetical protein OsI_002780 [Oryza sativa (indica cultivar-group)] 
hypothetical protein OsI_004782 [Oryza sativa (indica cultivar-group)] 
hypothetical protein PC301050.00.0 [Plasmodium chabaudi chabaudi] 
hypothetical protein Pfl_3860 [Pseudomonas fluorescens PfO-1] 
hypothetical protein PH0744 [Pyrococcus horikoshii OT3] 
hypothetical protein PMM1513 [Prochlorococcus marinus subsp. pastoris str. CCMP1986] 
hypothetical protein Ppro_1975 [Pelobacter propionicus DSM 2379] 
hypothetical protein PST_0570 [Pseudomonas stutzeri A1501] 
hypothetical protein RUMTOR_00917 [Ruminococcus torques ATCC 27756] 
hypothetical protein SareDRAFT_0666 [Salinispora arenicola CNS205] 
hypothetical protein Sbal195DRAFT_0316 [Shewanella baltica OS195] 
hypothetical protein SNOG_03450 [Phaeosphaeria nodorum SN15] 
hypothetical protein SNOG_14343 [Phaeosphaeria nodorum SN15] 
hypothetical protein SPAC18G6.03 [Schizosaccharomyces pombe 972h-] 
hypothetical protein Sputw3181_0469 [Shewanella sp. W3-18-1] 
hypothetical protein Tc00.1047053509601.30 [Trypanosoma cruzi strain CL Brener] 
hypothetical protein TTHERM_00145010 [Tetrahymena thermophila SB210] 
hypothetical protein TTHERM_00349000 [Tetrahymena thermophila SB210] 
hypothetical protein TVAG_346800 [Trichomonas vaginalis G3] 
hypothetical protein UM03791.1 [Ustilago maydis 521] 
hypothetical protein UM05511.1 [Ustilago maydis 521] 
hypothetical protein WH5701_07924 [Synechococcus sp. WH 5701] 
hypothetical protein, conserved [Leishmania braziliensis] 
ibosomal protein L1p [Plasmodium yoelii yoelii str. 17XNL] 
isocitrate dehydrogenase (NADP+) [Nicotiana tabacum] 
Isocitrate dehydrogenase 1 (NADP+), soluble [Homo sapiens] 
isocitrate dehydrogenase, NADP-dependent [Sphingopyxis alaskensis RB2256] 
K18, simple type I keratin [Oncorhynchus mykiss] 
keratin 15 [Danio rerio] 
keratin 18 [Danio rerio] 
Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
lactate dehydrogenase-A [Epinephelus coioides] 
lactate dehydrogenase-A; NAD+:lactate oxidoreductase; LDH-A [Chromis punctipinnis] 
lamin b2 [Danio rerio] 
late histone L3 H2b [Strongylocentrotus purpuratus] 
lipoprotein [Sinorhizobium meliloti] 
L-lactate dehydrogenase A chain (LDH-A) 
L-lactate dehydrogenase A chain (LDH-A) 
LOC397850 protein [Xenopus laevis] 
M116.5 [Caenorhabditis elegans] 
Matrix protein 
methyl-accepting chemotaxis sensory transducer [Pseudoalteromonas atlantica T6c] 
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, 
methenyltetrahydrofolate cyclohydrolas 
Methyltransferase type 12 [Shewanella denitrificans OS217] 
methyltransferase, FkbM family protein [Campylobacter fetus subsp. fetus 82-40] 
MGC108369 protein [Xenopus tropicalis] 
MGC75629 protein [Xenopus tropicalis] 
MGC79035 protein [Xenopus laevis] 
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minichromosome maintenance complex component 7 [Mus musculus] 
mitochondrial isocitrate dehydrogenase 2-like [Oreochromis mossambicus] 
mitochondrial malate dehydrogenase 2, NAD [Tamandua tetradactyla] 
M-TAXREB107 [Mus musculus] 
mucin-associated surface protein (MASP) [Trypanosoma cruzi strain CL Brener] 
muscle actin [Lethenteron japonicum] 
myosin regulatory light chain [Scophthalmus maximus] 
myosin, heavy polypeptide 9, non-muscle [Homo sapiens] 
N-acetylneuraminate lyase subunit [Staphylococcus saprophyticus subsp. saprophyticus 
ATCC 15305] 
nascent polypeptide-associated complex (NAC) domain-containing protein [Arabidopsis 
thaliana] 
nascent polypeptide-associated complex alpha subunit [Homo sapiens] 
natural killer enhancing factor [Paralichthys olivaceus] 
natural killer enhancing factor [Scophthalmus maximus] 
NHP2 non-histone chromosome protein 2-like 1 [Danio rerio] 
NHP2 non-histone chromosome protein 2-like 1 [Ictalurus punctatus] 
Nonspecific lipid-transfer protein (Propanoyl-CoA C-acyltransferase) (NSL-TP) (Sterol 
carrier prote 
nucleolin 2 [Cyprinus carpio] 
nucleoside diphosphate kinase [Oreochromis mossambicus] 
Nucleoside diphosphate kinase [Prochlorococcus marinus str. MIT 9211] 
nucleotide-sugar transporter, putative [Aspergillus fumigatus Af293] 
omega class glutathione-S-transferase [Takifugu rubripes] 
Os01g0805900 [Oryza sativa (japonica cultivar-group)] 
P4hb-prov protein [Xenopus tropicalis] 
p68 RNA helicase [Xenopus laevis] 
P68-LIKE PROTEIN (DEAD BOX FAMILY OF RNA HELICASES) [Encephalitozoon 
cuniculi GB-M1] 
paREP2b [Pyrobaculum aerophilum str. IM2] 
PAS/PAC sensor signal transduction histidine kinase [Flavobacterium johnsoniae UW101] 
Peptidyl-prolyl cis-trans isomerase B1 precursor (PPIase B1) (Rotamase B1) 
peroxiredoxin 3 [Bos taurus] 
peroxiredoxin 4 [Bos taurus] 
phenylacetate-coenzyme A ligase [Desulfovibrio vulgaris subsp. vulgaris str. 
Hildenborough] 
phosphogluconate dehydrogenase [Mus musculus] 
Phosphoglycerate kinase [Rhodobacter sphaeroides ATCC 17025] 
phosphoglycerate mutase [Chelon labrosus] 
phosphoglycerate mutase 1 family [Acidovorax sp. JS42] 
phosphoglyceromutase [Bacteroides fragilis YCH46] 
P-II family protein [Chlorobium tepidum TLS] 
Pkm2 protein [Danio rerio] 
polyubiquitin [Fragaria x ananassa] 
PPAT5 [Hyaloperonospora parasitica] 
Precorrin-6y C5,15-methyltransferase, subunit CbiE [Sagittula stellata E-37] 
predicted protein [Ostreococcus lucimarinus CCE9901] 
PREDICTED: AHNAK nucleoprotein 2 [Pan troglodytes] 
PREDICTED: hypothetical protein [Gallus gallus] 
PREDICTED: hypothetical protein [Gallus gallus] 
PREDICTED: hypothetical protein [Monodelphis domestica] 
PREDICTED: hypothetical protein [Monodelphis domestica] 
PREDICTED: hypothetical protein [Monodelphis domestica] 
PREDICTED: similar to 40S ribosomal protein S10 [Macaca mulatta] 
PREDICTED: similar to 40S ribosomal protein S20 [Macaca mulatta] 
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PREDICTED: similar to 60 kDa heat shock protein, mitochondrial precursor (Hsp60) (60 
kDa chaperonin 
PREDICTED: similar to 60S ribosomal protein L23a [Canis familiaris] 
PREDICTED: similar to 60S ribosomal protein L23a [Macaca mulatta] 
PREDICTED: similar to 60S ribosomal protein L32 [Canis familiaris] 
PREDICTED: similar to 60S ribosomal protein L35 [Bos taurus] 
PREDICTED: similar to actinin, partial [Danio rerio] 
PREDICTED: similar to Activator 1 140 kDa subunit (Replication factor C large subunit) 
(A1 140 kDa  
PREDICTED: similar to alpha-1 tubulin, partial [Strongylocentrotus purpuratus] 
PREDICTED: similar to alpha-2-macroglobulin isoform 1 [Bos taurus] 
PREDICTED: similar to CG16944-PA, isoform A [Tribolium castaneum] 
PREDICTED: similar to CG4046-PA [Tribolium castaneum] 
PREDICTED: similar to CG5826-PA [Tribolium castaneum] 
PREDICTED: similar to CG9277-PB, isoform B [Tribolium castaneum] 
PREDICTED: similar to dynein, cytoplasmic, heavy polypeptide 1 isoform 6 [Canis 
familiaris] 
PREDICTED: similar to expressed in non-metastatic cells 1, protein (NM23A) (nucleoside 
diphosphate  
PREDICTED: similar to Gsn protein isoform 1 [Danio rerio] 
PREDICTED: similar to H2A histone family, member Z [Mus musculus] 
PREDICTED: similar to Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) 
[Canis famili 
PREDICTED: similar to heat shock protein 84b [Monodelphis domestica] 
PREDICTED: similar to heat shock protein protein [Strongylocentrotus purpuratus] 
PREDICTED: similar to histone 1, H2ai (predicted) isoform 1 [Canis familiaris] 
PREDICTED: similar to histone H2b-616 [Bos taurus] 
PREDICTED: similar to hoip-prov protein [Strongylocentrotus purpuratus] 
PREDICTED: similar to Keratin, type I cytoskeletal 18 (Cytokeratin 18) (K18) (CK 18) 
[Canis familiaris] 
PREDICTED: similar to KIAA0152, [Danio rerio] 
PREDICTED: similar to KIAA1641 protein isoform 6 [Pan troglodytes] 
PREDICTED: similar to LOC494641 protein [Strongylocentrotus purpuratus] 
PREDICTED: similar to Myelin P2 protein [Gallus gallus] 
PREDICTED: similar to nonmuscle myosin heavy chain [Danio rerio] 
PREDICTED: similar to OTTHUMP00000028706 [Danio rerio] 
PREDICTED: similar to OTTHUMP00000028706, partial [Danio rerio] 
PREDICTED: similar to PLC alpha [Monodelphis domestica] 
PREDICTED: similar to Probable leucyl-tRNA synthetase, mitochondrial precursor 
(Leucine--tRNA ligas 
PREDICTED: similar to ribosomal protein isoform 1 [Pan troglodytes] 
PREDICTED: similar to ribosomal protein S15a [Rattus norvegicus] 
PREDICTED: similar to ribosomal protein S2 [Macaca mulatta] 
PREDICTED: similar to ribosomal protein S27a [Mus musculus] 
PREDICTED: similar to SMT3 suppressor of mif two 3 homolog 2 isoform 1 [Rattus 
norvegicus] 
PREDICTED: similar to solute carrier family 14 (urea transporter), member 1 [Canis 
familiaris] 
PREDICTED: similar to squamous cell carcinoma antigen recognized by T cells 3 [Apis 
mellifera] 
PREDICTED: similar to Thioredoxin-dependent peroxide reductase, mitochondrial 
precursor (Peroxiredo 
PREDICTED: similar to tubulin alpha 6 [Danio rerio] 
PREDICTED: similar to Tubulin alpha-1 chain [Tribolium castaneum] 
PREDICTED: similar to Tubulin alpha-2 chain (Alpha-tubulin 2) [Canis familiaris] 
PREDICTED: similar to Tubulin beta-6 chain (Beta-tubulin class-VI) [Danio rerio] 
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PREDICTED: similar to ubiquitin A-52 residue ribosomal protein fusion product 1 isoform 1 
[Mus musc 
probable acyl-CoA dehydrogenase [Cellulophaga sp. MED134] 
probable serine/threonine protein kinase [Rhodopirellula baltica SH 1] 
probableacetyltransferase/hydrolase [delta proteobacterium MLMS-1] 
procollagen, type IV, alpha 1, isoform CRA_a [Rattus norvegicus] 
Proliferating cell nuclear antigen (PCNA) (Cyclin) 
proliferating cell nuclear antigen [Bombyx mori] 
proliferation-associated 2G4, a [Danio rerio] 
protease, serine, 3 [Mus musculus] 
proteasome (prosome, macropain) subunit, alpha type 1 [Rattus norvegicus] 
proteasome (prosome, macropain) subunit, beta type, 3 [Danio rerio] 
proteasome 26S non-ATPase subunit 11 [Homo sapiens] 
proteasome alpha 3 subunit isoform 1 [Homo sapiens] 
proteasome beta 1 subunit [Homo sapiens] 
protein disulfide isomerase-related protein (provisional) [Danio rerio] 
protein disulfide-isomerase (EC 5.3.4.1) precursor - Caenorhabditis elegans (fragment) 
protein disulfide-isomerase [Ictalurus punctatus] 
protein Y6B3B.8 [imported] - Caenorhabditis elegans 
putative Aspartyl-tRNA synthetase [Oryza sativa (japonica cultivar-group)] 
putative DNA mismatch repair protein [Vibrio cholerae B33] 
putative eukaryotic translation initiation factor 4A [Silene latifolia] 
putative head-tail adaptor [Escherichia coli O157:H7 str. Sakai] 
putative primase [Lactococcus bacteriophage phi31] 
putative response regulator [marine gamma proteobacterium HTCC2207] 
putative ribosomal protein L7 protein [Oncorhynchus mykiss] 
putative signal peptide protein [Ralstonia pickettii 12J] 
putative TonB-dependent outer membrane receptor protein [Bacteroides fragilis NCTC 
9343] 
putative transient receptor protein 2 [Pagrus major] 
Putative transposase, mutator type [Burkholderia xenovorans LB400] 
quail calpain [Coturnix coturnix] 
RAB18, member RAS oncogene family [Homo sapiens] 
RAB18, member RAS oncogene family variant [Homo sapiens] 
ras-related GTP-binding protein RAB10 [Canis lupus familiaris] 
Ras-related protein ORAB-1 
rCG64140 [Rattus norvegicus] 
Rho GTPase [Dictyostelium discoideum AX4] 
ribosomal protein homologous to yeast S24 [Homo sapiens] 
Ribosomal protein L10a [Danio rerio] 
ribosomal protein L11 [Branchiostoma belcheri] 
ribosomal protein L11 [Mus musculus] 
ribosomal protein L13 [Branchiostoma lanceolatum] 
ribosomal protein L13a [Danio rerio] 
ribosomal protein L14 - human 
ribosomal protein L17 [Homo sapiens] 
ribosomal protein L19 [Xenopus laevis] 
ribosomal protein L21 [Siniperca chuatsi] 
ribosomal protein L23 [Canis lupus familiaris] 
ribosomal protein L27a [Plasmodium yoelii yoelii str. 17XNL] 
ribosomal protein L34 [Branchiostoma belcheri tsingtaunese] 
ribosomal protein L36 [Gallus gallus] 
ribosomal protein L4 [Pagrus major] 
ribosomal protein L5 [Mus musculus] 
Ribosomal protein L6 [Canis familiaris] 
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Ribosomal protein L6 [Danio rerio] 
ribosomal protein L7 [Oryzias latipes] 
ribosomal protein Large P0 [Protopterus dolloi] 
ribosomal protein S13 [Xenopus tropicalis] 
ribosomal protein S14 [Rattus norvegicus] 
ribosomal protein S20 [Solea senegalensis] 
Ribosomal protein S20 CG15693-PA [Drosophila melanogaster] 
ribosomal protein S27 [Homo sapiens] 
ribosomal protein S29 [Danio rerio] 
ribosomal protein S3 [Danio rerio] 
ribosomal protein S3 [Moniliophthora perniciosa] 
ribosomal protein S4, X-linked [Monodelphis domestica] 
ribosomal protein S8 [Gillichthys mirabilis] 
ribosomal protein S8 [Protopterus dolloi] 
ribosomal protein S9 [Homo sapiens] 
ribosomal protein S9 [Plutella xylostella] 
ribosomal protein, large, P0 [Danio rerio] 
RNA binding protein p37 AUF1 [Rattus norvegicus] 
rpL14 protein [Takifugu rubripes] 
RPS28 (RIBOSOMAL PROTEIN S28); structural constituent of ribosome [Arabidopsis 
thaliana] 
rs23 protein [Ciona intestinalis] 
S11 ribosomal protein [Sparus aurata] 
S14e ribosomal protein-like protein [Philodina sp. NPS-2005] 
S-adenosyl-L-homocysteine hydrolase [Blastopirellula marina DSM 3645] 
S-adenosyl-L-homocysteine hydrolase [Prosthecochloris aestuarii DSM 271] 
SEC22 vesicle trafficking protein-like 1 [Mus musculus] 
Serum albumin precursor (Allergen Bos d 6) (BSA) 
SET translocation [Mus musculus] 
signal transduction histidine kinase, nitrate/nitrite-specific, NarQ [Methylobacillus 
flagellatus KT] 
similar to alpha-Tubulin at 84B [Xenopus laevis] 
simple type II keratin K8b (S2) [Oncorhynchus mykiss] 
SMT3 supressor of mif two 3 homolog 2 [Mus musculus] 
Sodium/potassium-transporting ATPase alpha-3 chain (Sodium pump 3) (Na(+)/K(+) 
ATPase 3) (Alpha(III 
solute carrier family 25, member 5 [Mus musculus] 
SSR gamma subunit [Rattus norvegicus] 
stratifin [Homo sapiens] 
stress protein HSC70 [Xiphophorus maculatus] 
suppressor [Xenopus laevis] 
t-complex polypeptide 1 chaperonin delta chain - Japanese pufferfish 
t-complex protein 4a - bovine (fragments) 
Temporarily Assigned Gene name family member (tag-210) [Caenorhabditis elegans] 
tetra-ubiquitin [Saccharum hybrid cultivar H32-8560] 
Tln1 protein [Danio rerio] 
TPA: TPA_inf: HDC03427 [Drosophila melanogaster] 
TPR repeat [Delftia acidovorans SPH-1] 
Transcriptional regulator, MarR/EmrR family [Clostridium acetobutylicum ATCC 824] 
transfer RNA-Ala synthetase [Bombyx mori] 
translation elongation factor 2 [Spodoptera exigua] 
transporter, NRAMP family protein [Flavobacteriales bacterium HTCC2170] 
transposase [Oceanicola batsensis HTCC2597] 
triose phosphate isomerase [Polypterus ornatipinnis] 
triose-phosphate isomerase [Cyanidioschyzon merolae] 
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triosephosphate isomerase [Saccoglossus kowalevskii] 
triosephosphate isomerase B [Xiphophorus maculatus] 
tropomyosin [Fundulus heteroclitus] 
tropomyosin 2, beta [Mus musculus] 
tropomyosin4-1 [Takifugu rubripes] 
troponin C-like protein 
Try10-like trypsinogen [Mus musculus] 
trypsin (EC 3.4.21.4) precursor - bovine 
TUA1 (ALPHA-1 TUBULIN) [Arabidopsis thaliana] 
tubulin [Geodia cydonium] 
tubulin alpha 6 [Danio rerio] 
Tubulin alpha chain 
tubulin beta chain - rat (fragments) 
Tubulin beta chain (Beta tubulin) 
Tubulin beta-2 chain (Beta-tubulin 2) 
tubulin, alpha 4, isoform CRA_b [Homo sapiens] 
tubulin, alpha 4b [Xenopus tropicalis] 
tubulin, alpha 8 [Gallus gallus] 
tubulin, alpha 8 like 3 [Danio rerio] 
tubulin, beta 2a [Xenopus tropicalis] 
Tubulin, beta 2C [Homo sapiens] 
Tubulin, Beta family member (tbb-4) [Caenorhabditis elegans] 
type 2 actin [Pleurochrysis carterae] 
type II keratin E3 [Oncorhynchus mykiss] 
type II keratin subunit protein 
ubiquitin 
ubiquitin 
ubiquitin [Scyliorhinus torazame] 
Ubiquitin family protein [Tetrahymena thermophila SB210] 
ubiquitin/actin fusion protein [Gymnochlora stellata] 
ubiquitin/actin fusion protein 2 [Bigelowiella natans] 
ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing) 
[Danio rerio] 
ubiquitin-like protein fubi and ribosomal protein S30 precursor [Homo sapiens] 
ubiquitin-like protein Ublp94.4 [Acanthamoeba castellanii] 
ubquitin/ribosomal protein S27Ae fusion protein [Curculio glandium] 
Unknown (protein for MGC:160678) [Xenopus laevis] 
Unknown (protein for MGC:82390) [Xenopus laevis] 
unknown [Homo sapiens] 
unknown [Schistosoma japonicum] 
unknown [Trichinella spiralis] 
unknown protein encoded by prophage CP-933K [Escherichia coli UTI89] 
unnamed protein product [Candida glabrata] 
unnamed protein product [Candida glabrata] 
unnamed protein product [Homo sapiens] 
unnamed protein product [Homo sapiens] 
unnamed protein product [Macaca fascicularis] 
unnamed protein product [Macaca fascicularis] 
unnamed protein product [Mus musculus] 
unnamed protein product [Mus musculus] 
unnamed protein product [Mus musculus] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
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unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
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unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
unnamed protein product [Tetraodon nigroviridis] 
uracil-DNA glycosylase [Borrelia burgdorferi B31] 
UvrD/REP helicase [uncultured Prochlorococcus marinus clone ASNC2150] 
valosin containing protein [Danio rerio] 
vf14-3-3c protein [Vicia faba] 
V-Fos transformation effector [Scophthalmus maximus] 
vitronectin precursor [Homo sapiens] 
voltage-dependent anion channel [Paralichthys olivaceus] 
voltage-dependent anion channel 2 [Gallus gallus] 
YlACT1 [Yarrowia lipolytica] 
Zgc:112271 protein [Danio rerio] 
Zgc:153867 protein [Danio rerio] 
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Table 3.6 Primers for the 11 newly identified viral proteins 
ORFs Left primer Right primer 
ORF049L ATGTACGTAT ACCCCGCAAT TCATTTTTTT TGCCTAACTC C 
ORF099R ATGCCCGTAT CAGATAAAGA TCATCTTTCA CAATTGGACA  
ORF107R ATGCAACGTT CCATAAATTT G TTACATGGCA GACTGCGCG 
ORF111R ATGGTGAATG AAATGTATAC A CTATAAAAGC GGGATGTTAA  
ORF118R ATGACCAGCC GGCGTTTC CTAAGCGAAT CCGAGCGTT 
ORF127R ATGTTAACCG CAATTGTAAC TTATTCGTTA AACGAATATC T 
ORF135L ATGGAAGAAC TCGTACAAGC TTACGGTTCC GGCGTCTT 
ORF136R ATGTACCCTG TATTGAAAAG TTATACAATT TTATAAACGG C 
ORF140R ATGTCAGAAT TTAGGGGTCA CTACGCTTTT TTATCCGCT  
ORF155R ATGGCACTAT TGATATCTAT TTACTCGCAA CTATCAATCA 







Chapter Four  
A novel SGIV-coding protein ORF158 is involved 




ORF158L, one of the 162 open reading frames (ORFs) predicted from the SGIV 
genome, is a functionally unknown gene. In this chapter, we report that: ORF158L (i) 
encodes a full length protein (~16Kd); (ii) is not essential for SGIV replication in cell 
culture; (iii) is not engaged in the transcriptional regulation of SGIV gene expression 
in cell culture; (iv) does not affect viral protein translation; (v) is highly accumulated 
in the host nucleus and viral assembly center; (vi) is co-localized with histone H3 of 
the host cells; (vii) is involved in the regulation of lysine 79 methylation of host 




Singapore Grouper Iridovirus (SGIV), an iridovirus of the ranavirus genus, was 
isolated from brown-spotted grouper in 1998 after they caused significant economic 
losses in Singapore marine net cage farms in 1994 (Chua et al., 1994; Qin et al., 
2001). In 2004, the genome of SGIV was sequenced, 162 Open Reading Frames 
(ORFs) were predicted based on the 140,131 base pair length viral genome, and 26 
SGIV proteins were identified (Song et al., 2004). Two years later, in 2006, additional 
25 SGIV viral proteins were reported by proteomics methods (Song et al., 2006).  
Although the proteins of 51 ORFs out of the 162 ORFs are reported, the translational 
products of the remaining 117 ORFs are unknown (Song et al., 2004; Song et al., 
2006). Recently, Chen and coworkers reported that 127 ORFs of SGIV were 
transcriptionally active (Chen et al., 2006). ORF158L was one of the 162 ORFs 
predicted in the SGIV genome. Although ORF158L was reported to be 
transcriptionally active and was classified as one of the SGIV early genes, the 
translational product and function of the ORF158L remain unknown (Chen et al., 
2006). The present study aims to elucidate the biological function of the ORF158L 
encoded protein. 
4.3 Materials and Methods 
4.3.1 Cell and virus infection 
Protocols for cell and virus infection were described earlier in Chapter 2. 
4.3.2 Antibodies 
The ORF158L gene was PCR amplified and cloned into pET-15b (Novagen). The 
recombinant protein was over expressed at 18 °C overnight with 0.1mM IPTG by 
using a BL21 strain (DE3; Novagen). The recombinant protein was first purified by 
using a Ni-NTA column (Qiagen) and was further purified by gel filtration 
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chromatography using a Superdex 75 column (Amersham). The purified protein was 
used for generation of monoclonal antibodies. Monoclonal antibodies against beta 
actin, polyclonal antibodies against histone H3 and K79 monomethylated histone H3 
were purchased from ABCAM. 
4.3.3 Knockdown of ORF158L 
Morpholinos sequence against ORF158L (158_MO) is  
5'-AGTTTGCTACGATGGCCCACCCCAT-3'. Control MO (Ctr_MO) sequence is 
5'-CCTCTTACCTCAGTTACAATTTATA-3'. MOs were delivered into GEC cells 
by electrophoresis using Nucleofactor (Amaxa). Forty hours after transfection, 5 MOI 
SGIV were added into the cells. And the samples were harvested at 48h p.i. for further 
investigations. 
4.3.4 Electron Microscopy 
The embryonic cells were fixed in 2.5% glutaraldehyde, 2% paraformaldehyde-PBS, 
postfixed with 1% osmium tetroxide, followed by dehydration and infiltration. The 
samples were sliced into ultra thin sections and stained with 2% uranyl acetate and 
1% lead citrate. The samples were examined with a Philips CM10 electron 
microscopy at 100 kv. 
4.3.5 DNA Microarray and Real Time RT PCR 
The methods for DNA Microarray and real time RT-PCR were described in chapter 2. 
4.3.6 Immunofluorescence  
Cells either treated or untreated with SGIV and morpholinos were cultured in Lab-
Tek® II CC2™ Chamber Slide™ (Nalge). In the case of SGIV infection, 5MOI SGIV 
were used and the cells were investigated 48h p.i. later. The procedure of immunolabeling 
is described next: first, the cells were washed with 1 × PBS; followed by the addition of 
fixation buffer (3% w/v) and 100% methanol (pre-cooled at -20°C) and subsequently 
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the samples were washed with 1 × PBS; after adding blocking buffer (1% BSA, 1 × 
PBS), samples were incubated with antibodies. 1 hour later, the samples were washed 
with 1 × PBS, followed by incubation with Alexa Fluor probes (Invitrogen) for 1 hour; 
subsequently, trihydrochloride (Invitrogen) was added to samples and the samples 
were washed with 1 × PBS. The chamber was removed and the sample was sealed 
with cover slides. Finally, the samples were observed using Olympus Fluoview 
FV500. 
4.4 Results 
4.4.1 Western blot against ORF158L When 158 mAbs was used to do western blots, 
no protein could be detected in the SGIV mock-infected cell lysate (Fig 4.1. A. 
Middle lane) and only one protein band was detected in the SGIV-infected cell lysate 
(Fig 4.1. A. First lane). The ORF158L expressed in SGIV-infected cells was the same 
molecular size as the tag-removed recombinant ORF158L proteins expressed in E. 
coli (Fig 4.1. A. First lane and third lane). This study demonstrated that ORF158L 
encoded a full length viral protein upon infection.  
4.4.2 Knockdown of ORF158L Fig 4.1. B shows no detectable ORF158L in the 
158_MO treated GEC with SGIV-infected when compared to the ORF158L in the 
CTR_MO treated GEC with SGIV-infected (Fig 4.1. B).This evidence shows that 
ORF158L was efficiently knocked down by anti-ORF158 MO (i.e. 158_MO).  
Under EM, there was minimal alteration of virus assembly, the morphology of mature 
SGIV particles did not change and the budding of SGIV particles was normal when 
ORF158L was knocked down (Fig 4.1. C).  
4.4.3 DNA Microarray and Real time RT-PCR investigation of transcriptomes of 
viral genes when ORF158Lwas knocked down There was no obvious variation in 
viral transcription upon ORF158L knockdown (Fig 4.2. A). Real time RT PCR results 
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of 7 ORFs were consistent with DNA microarray data showing that the transcription 
of viral genes was not significantly affected when we   knocked down ORF158L (Fig 
4.2. B&C).  
4.4.4 Subcellular localization of ORF158L and ORF158L & Histone H3 
colocalization At late SGIV-infected stage (i.e. 48h p.i.), the morphology of nucleus 
of host cells (i.e. GECs) was significantly altered (Fig 4.3.). The inter chromosome 
spaces in host nucleus were dramatically increased at the late stage of SGIV-infected 
and ORF158L accumulated in the host nuclear and viral assembly center (Fig 4.3). In 
the 158_MO treated cells, no fluorescent signals corresponding to ORF158L were 
detected (Fig 4.3. N). This phenomenon confirmed that ORF158L was successfully 
knocked down.  
Furthermore, the colocalization of ORF158L and histone H3 at host cell nucleus was 
observed using immunofluorecence (Fig  4.4).  
4.4.5 iTRAQ study of the effect of ORF158L knockdown at proteome scale 
iTRAQ data identified 51 viral proteins and all these viral proteins were not 
significantly  changed when we knocked down ORF158L during SGIV-infection (Fig 
4.7). Given the unknown nature of the host genome, only 700 plus host proteins were 
identified from the iTRAQ data and most of the identified host proteins were not 
notably changed when we knocked down ORF158L during SGIV infection compared 
to those without ORF158L knockdown during SGIV infection (Data not shown).  
4.4.6 ORF158L is involved in Histone H3 lysine 79 (K79) methylation regulation 
iTRAQ data showed that host histone H3 were up-regulated when we knocked down 
ORF158L during SGIV-infection (Figure 4.5). To validate this finding, we carried out 
western blot against histone H3 by using the commercial polyclonal antibodies 
against histone H3 . Surprisingly, the total histone H3 was not up-regulated when we 
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knocked down ORF158L during SGIV-infection (Figure 4.6). Because we did not 
include any kind of post translational modification when we analyzed the iTRAQ data, 
the iTRAQ data only showed that the non modified form of histone H3 was down-
regulated upon SGIV infection. Given that total histone H3 did not change when we 
knocked down ORF158L during SGIV infection, we suspected that the modified form 
of histone H3 might be down-regulated. Histone H3 can undergo many kinds of post 
translational modifications, such as methylation, acetylation, and phosphorylation. To 
determine what kind of modification could account for the findings presented above, 
we reexamined the iTRAQ raw data, and found that the peptide “EIAQDFKTDLR” 
of histone H3 was the only peptide identified from iTRAQ analysis and the non 
modified form of this histone H3 peptide was up-regulated when we knocked down 
ORF158L during SGIV infection. This histone H3 peptide sequence 
“EIAQDFKTDLR” contains a lysine (i.e. K), which is referred as K79 in histone H3 , 
and this K79 can undergo methylation. We proposed that K79 methylated form of 
histone H3 could be down-regulated. A combination of up regulation of the K79 
methylation form of histone H3 and down-regulation of K79 non-methylated histone 
H3 would make the total histone H3 unchanged. To test this hypothesis, we carried 
out western blots against K79 methylated histone H3 by using the specific polyclonal 
antibodies against K79 methylation form of histone H3. The results are shown in 
Figure 4.6. The first panel shows that the K79 methylation form of histone H3 was 
up-regulated upon SGIV-infected and down-regulated when we knocked down 
ORF158L during SGIV infection; the second panel shows that total histone H3 was 
not changed; the third panel shows that ORF158L was successfully knocked down; 
the bottom panel shows beta actin, which was used as controls, were not changed 
(Figure 4.6). By combining the iTRAQ and western blot data, we can conclude that 
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K79 monomethylation of histone H3 was up-regulated when GECs were infected by 
SGIV. When ORF158L was knocked down in SGIV-infected GECs, the K79 
monomethylation of histone H3 was down-regulated compared to those SGIV-
infected GECs without ORF158L knockdown (Figure 4.6).  
4.5 Discussion 
A total of 12 iridovirus genomes including SGIV has been sequenced (Tidona and 
Darai, 1997; He et al., 2001; Jakob et al., 2001; He et al., 2002; Jancovich et al., 
2003; Do et al., 2004; Tan et al., 2004; Zhang et al., 2004; Song et al., 2004; Tsai et 
al., 2005; Lu et al., 2005; Delhon et al., 2006). Genomic annotations have predicted a 
number of ORFs based on the genomic sequences. In SGIV, a total of 162 ORFs was 
predicted on the basis of the viral genomic sequence, and only 23 are highly 
homologous to other iridovirus proteins with specific biological functions (Song et al., 
2004). To date, only 45 viral proteins out of the 162 ORFs have been detected at the 
protein level using mass spectrometry (Song et al., 2004; Song et al., 2006). Recently, 
127 ORFs out of the 162 ORFs have been characterized at the transcriptional level 
and are classified into three groups (i.e. immediate early, early and late genes) (Chen 
et al., 2006). Although ORF158L has been classified to be an early gene, the 
corresponding proteins and its functions remain unknown (Chen et al., 2006). In this 
study, we found that ORF158L was involved in the regulation of histone H3 K79 
methylation. 
Besides methylation, histone H3 can be acetylated and phosphorylated,  and these 
modifications affect gene expression (Zhang and Reinberg, 2001; Lacoste et al., 2003; 
Li et al., 2007). The different modifications of histone H3 , including acetylation, 
phosphorylation, and methylation, have different functions. For example, acetylations 
of histone H3 are generally related to transcriptional activation, while, methylations of 
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histone H3 are connected with both transcriptional activation and transcriptional 
repression (Roth et al., 2001. ; Zhang and Reinberg,  2001). The methylation of 
histone H3 can either be lysine methylation or arginine methylation. The K4, K9, K27, 
K36 and K79 of H3 have been reported to have potential to be methylated (Li et al., 
2007). Generally, the methylation of K9 and K27 of histone H3 are related to 
transcriptional repression, whereas, K4, K36 and K79 of histone H3 are linked to 
transcriptional activation (Martin and Zhang, 2005). Although K79 methylation of 
histone H3 was regarded to be linked with gene transcriptional activation, the viral 
coding protein regulated the host histone H3 K79 methylation were still unknown. We 









Figure 4.1 Identification and knockdown of ORF158L in cell culture. A.) Upper panel 
is western blot by using monoclonal antibodies against ORF158L. Lower panel is 
western blot by using beta actin monoclonal antibodies. First lane is the cell lysate of 
GECs which are 48 hours post infection with 5MOI SGIV. Second lane is the cell 
lysate of mock SGIV-infected GECs. Third lane is the purified ORF158L protein with 
his-tag cleaved by thrombin. B.) First lane is the cell lysate of anti 158 morpholinos 
(158_MO) treated GECs which are 48 hours post infection with 5MOI SGIV. Second 
lane is the cell lysate of control morpholinos (Ctr_MO) treated GECs which are 48 
hours post infection with 5MOI SGIV. C.) Left is the EM picture of a section of 
158_MO treated GECs which are 48 hours post infection with 5MOI SGIV. Right is 
the EM picture of a section of Ctr_MO treated GECs which are 48 hours post 













































Figure 4.2 A comparison of transcriptional profiles of SGIV with and without 
ORF158L knock down. A.) X axis is the DNA microarray data of Control 
morpholinos (Ctr_MO) treated GECs which are 48 hours post infection with 5MOI 
SGIV normalized to beta actin. Y axis is the DNA microarray data of anti 158 
morpholinos (158_MO) treated GECs which are 48 hours post infection with 5MOI 
SGIV normalized to beta actin.  B.) Fold changes between 158_MO treated and 
Ctr_MO treated DNA microarray data of random selected ORFs. X axis lists the 
random selected ORFs.Y axis is the fold changes of selected ORFs when we 
compared the normalized DNA microarray data of 158_MO to Ctr_MO. C.) The 
investigations of the fold changes between 158_MO treated and Ctr_MO treated 







Figure 4.3 Subcellular localization of ORF158L. Blue colors represent DAPI staining ds DNA. 
Green color represents the ORF158L. 
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Figure 4.5. iTRAQ study of ORF158L knockdown effects to histone H3. When the  
SGIV-infection GECs with 158_MO treatment was compared to those with 
CTR_MO treatment at proteomics scale by iTRAQ, non modification form of histone 











Figure 4.6. Western blot of histone H3 modification. First lane represents SGIV mock-
infected GEC; second lane represents SGIV-infected GEC; third lane represents SGIV-
infected GEC with CTR_MO treatment; fourth lane represents SGIV-infection GEC with 
158_MO treatment. First panel represents K79 monomethylation form of histone 3; second 
panel represents histone 3; third panel represents ORF158L; fourth panel represents beta 
actin. 
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Figure 4.7. iTRAQ study of ORF158L knockdown effects in SGIV-infected GECs. Viral protein 
comparison between SGIV-infection GECs with 158_MO treatment and those with CTR_MO 
treatment at proteomic scale by iTRAQ shows that the synthesis of viral proteins were not inhibited 








Structural study of ORF158L-coded protein 
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5.1 Summary & Introduction 
The functional studies show that ORF158L is involved in the regulation of host 
histone H3 K79 methylation. In this chapter, we report the structural study of 
ORF158L. After we failed to solve the structure of ORF158L by NMR, we solved the 
structure of ORF158L by X-ray crystallography at 1.8 Å resolution. The structure of 
ORF158L is highly similar to ASF1, which is an anti-silencing factor involved in 
nucleosome assembly. We also verified that ORF158L can bind to H3 & H4 complex 
with sub-micromolar binding affinity using SPR.  
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5.2 Materials and Methods 
5.2.1 Construction of the expression plasmid 
Full length DNA coding sequence of ORF158L, which coded 138 amino acids, was 
amplified by PCR from the SGIV genome and the PCR products were further cloned 
into the pET-15b vector. The sequence was verified by DNA sequencing. The 
resulting construct was transformed into DE3-star strain for protein expression. 
5.2.2 Expression and purification of ORF158L 
Large scale expression of ORF158L was done by the following procedure: the 
transformed cells were cultured in LB with 100µg/ml of ampicillin; 0.2mM IPTG was 
added when OD600 value of cells reached 1.0; ORF158L was induced to overexpress 
by culturing the cells at 18°C over night. The gene product of ORF158L was purified 
under native conditions by Ni-NTA chromatography (Qiagen) and his-tag was 
cleaved by thrombin. The elutes from Ni-NTA column were further purified by 
SuperdexTM 75, followed by mono Q ion exchange chromatography. 
5.2.3 Mass spectrometry analysis 
Purified ORF158L was subjected to MALDI-TOF mass spectrometry to verify its 
molecular mass.  
5.2.4 Dynamic light scattering (DLS) study 
In order to assess the homogeneity of ORF158L, the purified protein was 
characterized using DLS with Dynapro instrument (Protein Solutions Inc). The data 
were analyzed by using Dynamics 5.0 (Moradian-Oldak, 1998 ). 
5.2.5 Circular dichroism (CD) study 
The secondary structure of ORF158L was characterized by CD. ORF158L was 
prepared in 10-20 mM sodium phosphate buffer, pH6.8. The experiment was 
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conducted in the far UV range (190-260 nm) with Jasco spectropolarimeter J-720 at 
25°C. 
5.2.6 NMR sample preparation 
15N and 15N/13C-labeled ORF158L were prepared in M9 medium with the addition of 
(15NH4)2SO4 for 
15N labeling and (15NH4)2SO4 and [
13C] glucose for 15N/13C double 
labeling, respectively. Samples for NMR spectroscopy were concentrated to 0.5 mM 
in the buffer which contained 20 mM sodium phosphate buffer with pH6.6, 1 mM 
Mg2Cl2, 5 mM 2-ME, 150 mM NaCl.  Finally, 450 µl of protein solution was mixed 
with 50µl of D2O (final concentration is 10%)  and transferred to an NMR tube 
(Cambridge Isotope Laboratories, Inc.). All samples were examined by 15% SDS-
PAGE after purification. 
5.2.7 NMR Experiments and data processing. 
All NMR spectra were acquired at 298K on a Bruker 800MHz spectrometer. All 
NMR data were processed with NMRPipe (Delaglio 1995.) and analyzed with 
NMRview (Johnson 1994.). Structure calculation could be performed with the 
program CYANA (Herrmann 2002.) and the phi and psi angle constraints could be 
generated from TALOS program (Cornilescu 1999). Ten conformers with the lowest 
final values of the CYANA target function could be chosen to represent the most 
probable structures. 
5.2.8 SeMet ORF158L preparation 
SeMet ORF158L  was prepared by using M9 SeMET growth media kits and 
following the manufacturer’s protocol (Medicilon).  
5.2.9 Crystallization  
Purified native ORF158L was concentrated to approximately 8 mg/ml in the buffer 
consisting of 20 mM Tris pH8.5, 150 mM NaCl, 1 mM MgCl2, 1 mM DTT. Initial 
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crystallization screening was performed using the sparse matrix approach using kits 
from Hampton Research (Screen I and II). The protein was crystallized by the 
hanging drop vapor diffusion method at 25°C.  The best crystals appeared when 
equilibrating against reservoir solution containing 3% glycerol, 18% PEG3350, 0.1 M 
Tris pH8.5, 0.3 M NaAc with a drop size of 1 µl protein solution mixed with 1 µl 
reservoir solution. Similar to the native ORF158, the recombinant SelMet ORF158 
was concentrated to approximately 8mg/ml in the same buffer as the native protein. 
SelMet substituted crystals were grown under essentially the same conditions as the 
native ORF158. In order to obtain bigger SelMet crystals macroseeding was 
employed.  The crystals grew to a final size of approximately ~0.2×0.2×0.05mm3 
(Figure 5.7).  
5.2.10 Data collection, structure solution and refinement 
Prior to data collection, both native and SelMet crystals were soaked in the reservoir 
solution with step wise increased concentrations of glycerol (5% glycerol, 10% 
glycerol, 15% glycerol, 20% glycerol, 25% glycerol) as cryo-protectant. Crystals were 
picked up in a nylon loop, and frozen at 100K in N2 (gas) cold stream. Synchrotron 
data were measured at beamline X29, NSLS, Brookhaven National Laboratory. 
Diffraction data were processed using the program HKL2000. For phase 
determination, the resolution range from 50 to 2.5Å was chosen.  Two of the three 
expected Se sites of one asymmetric unit were found using the program BNP. BNP 
was further used to automatically build 90% of the total model. Remaining parts of 
the model were built manually using the program O. Further cycles of model building, 
alternating with refinement using the program CNS resulted in the final model, with 
an R-factor of 0.207 (Rfree=0.245). The data collection and refinement statistics of 
ORF158 was listed in Table 5.1. 
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5.2.11 Expression and purification of H3 and H4 complex 
The plasmid, which co-expresses histone H3 and H4, was kindly provided by Dr. 
James T. Kadonaga. Large scale expression of recombinant H3 and H4 was 
performed by the following procedure: transformed cells were cultured in LB with 
100µg/ml of ampicillin; 0.4mM IPTG was added when OD600 value of cells reached 
0.6; Recombinant H3 and H4 was induced to overexpress by culturing the cells at 
37°C for 2 hours. Unless stated otherwise, all subsequent operations were performed 
at 4 °C. The cells were pelleted by centrifugation (4,000g, 17min). The pellets were 
resuspended in the buffer (20 ml/liter bacterial cell culture), which contains 10 mM 
Hepes (pH7.6), 0.1 M NaCl, 10% (v/v) glycerol, 1 mM dTT, and lysed by three 
cycles of sonication of 30 s each. The lysate was subjected to centrifugation (10,000 g, 
30 min), and the supernatant was discarded. The pellet was suspended in 0.25 N HCl 
(10ml/liter bacterial cell culture) and dispersed with a dounce homogenizer. The 
resulting suspension was incubated at -20 °C for 30 min and subjected to 
centrifugation (10,000 g, 60 min). The supernatant was collected and neutralized with 
0.17 volumes of 2M Tris base. The H3-H4 tetramers were purified by monoS 
chromatography (flow rate = 0.8ml/min; fraction size = 0.5 ml). Protein was eluted 
with a linear gradient (20 ml) from 0.1 to 2 M NaCl in the buffer, which contains 10 
mM Hepes (pH7.6), 0.1 M NaCl, 10% (v/v) glycerol, 1 mM dTT. The H3 and H4 
complex was eluted at about 1 M NaCl. (Figure 5.8)  
5.2.12 Surface Plasmon Resonance (SPR) 
Surface plasmon resonance (SPR) was carried out on a BIACORE 3000 instrument, 
which uses SPR technology to investigate the interactions of macromolecules with 
each other and with small ligands by immobilizing one of the ligands on a gold 
surface followed by flowing the second partner (analyte) over the immobilized ligand 
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surface. One hundred microliters of 25µg/ml histone H3 and H4 complex were 
captured on the CM5 (Biacore). After ligand immobilization on the analyte cell, both 
the analyte and the reference cells were washed with the histone binding buffer (10 
mM HEPES [pH 7.4], 150 mM NaCl, and 0.005% Surfactant P20). Serial dilution 
from 0.1 µM to 25 µM of ORF158L protein sample was injected across the chip. 
Binding proteins were removed by 10 microliters of 100 mM HCl after each 
dissociation cycle. The data were fitted to a 1:1 binding mode with mass transfer 
effect using the BIAevaluation 3.1 software (BIAcore). 
5.3 Results & Discussion 
5.3.1 Protein purification profiles of ORF158L  
ORF158L was cloned into the pET-15b vector, expressed as a soluble form, purified 
with AF, SEC, and IEC to achieve the appropriate homogeneity level for downstream 
studies. The chromatography profile of ORF158L is shown in Figure 5.1. 
5.3.2 Mass spectrometry analysis 
The molecular mass of ORF158L is 16050 Dalton, which matched the theoretical 
M.W. of 16069 Dalton. The SeMET ORF158L is 16240 Da (Figure 5.2), which 
means all 4 methionines in ORF158L were replaced by Se-Met. The sequence here is 
referring to the full length of ORF158L (15770 Da) plus GSH residues (299 Da) at the 
N-terminal of recombinant ORF158L after thrombin cleavage of the his tag. 
5.3.3 Dynamic light scattering (DLS) study 
The DLS data shows that ORF158L behaves as a 81.8 kDa protein by aggregating to 
be ORF158L polymers (Figure 5.3).  
5.3.4 Circular dichroism study 
The CD spectrum measured in the far UV region (190-260nm) showed that the 
secondary structure of ORF158L is β sheet-dominant (Figure 5.4). 
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5.3.5 1D NMR 
A simple one-dimensional proton experiment is the most basic spectrum in NMR 
spectroscopy that can be acquired in a short time (usually not longer than a few 
minutes) for samples as dilute as 0.01 mM. It provides us the folding status of 
proteins (i.e. a protein is folded or unfolded). The protein folding status is important 
for any further functional or structural studies on the protein as only folded proteins 
retain their functional activity and three-dimensional structure. Figure 5.5 A shows a 
typical one-dimensional proton NMR spectrum of a folded protein (upper panel) and a 
typical one-dimensional proton NMR spectrum of an unfolded protein (lower panel). 
The folded protein shows signal dispersion downfield (left) of 8.5 ppm and upfield (to 
the right) of 1 ppm in one-dimensional proton NMR spectrum. With comparison, an 
unfolded protein sample shows strong signals around 8.3 ppm, which is the region 
characteristic for amide groups in random coil conformation, and no signal dispersion 
below approximately 8.5 ppm, and also no further signals to the right of the strong 
methyl peak at 0.8 ppm (Figure 5.5 A). Figure 5.5 B shows the 1D NMR spectra of 
ORF158L. The 1D NMR spectra of ORF158L identifies that ORF158L is a well folded 
protein (Figure 5.5 B). The signal dispersion upfield (to the right) of 0 ppm in one-
dimension proton NMR spectrum indicates that ORF158L is a well folded and beta 





N HSQC study of ORF158L 
A one-dimensional spectrum of the protein molecule contains overlapping signals from 
many hydrogen atoms because the differences in chemical shifts are often smaller than 
the resolving power of the experiment. This problem has been bypassed by designing 
experimental conditions that yield a two-dimensional NMR spectrum. Compared to 1H-
15N HSQC spectrum of ORF129, which is another protein coded in the SGIV genome, 
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1H-15N HSQC spectrum of ORF158L shows much better dispersions (Figure 5.6). 
However, about 20% of the backbone amino acids signals were undetectable in the 
1H-15N HSQC spectrum of ORF158L. This phenomenon indicates that ORF158L may 
have dynamic regions. As a result, we failed to solve the structure of ORF158L by 
NMR.  
5.3.7 Overall structure of ORF158L 
The structure of recombinant SelMet ORF158 of SGIV was solved by the 
multiwavelength anomalous dispersion (MAD) method from synchrotron data and 
refined to a present R-factor of 0.207 (Rfree=0.245) at 1.8 Å resolution. Statistics for 
the Ramachandran plot from an analysis using PROCHECK gave over 86% of 
nonglycine residues in the most favored region and 0% residues in the disallowed 
region.  The asymmetric unit consists of an ORF158 molecule comprising 133 
residues from Ile5 to Ala137. Neither the N-terminal four residues nor the last 
residues at the C-terminal had interpretable density and were not modeled. The 
organization of ORF158 molecules in the crystal is consistent with it being a 
monomer in the solution studies such as gel filtration experiments. Figure 5.9 A 
shows the ribbon representation of the crystal structure of ORF158. 
ORF158 molecule consists mainly of two β-sheets each consists of four and seven 
antiparallel β-strands respectively and forms an elongated β- sandwich domain. In 
addition, two short α-helices on one surface of the molecule with several loops 
between the secondary structures. The overall architecture of ORF158 resembles an 
immunoglobulin-like fold. The cavity at the β-sandwich domain is predominantly 
hydrophobic in nature. We suggest that the cavity may recognize a specific small 
hydrophobic ligand and interact with side chains of the cavity residues. However the 
exact roles of this cavity are not yet established.  
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The structure of ORF158 has a concave surface on one side of the β-sandwich domain. 
This concave surface spread across strands from β9 to β11 of the β-sheet.  The 
calculated electrostatic surface potential shows strong negative charge in the concave 
region. It is worth mentioning here that several conserved residues of ORF158 are 
located in this region and would suggest an important functional role for this surface 
feature.  Our functional data suggest that ORF158 is a histone binding protein and we 
speculate that this function could be related to this structural feature.  
5.3.8 Sequence and structural homology 
Blast searches revealed that ORF158 has no significant sequence homology with any 
protein with known function. However it exhibits a maximum identity of less than 
18% with two hypothetical proteins from Ostreococcus lucimarinus and Laccaria 
bicolor. A search for topologically similar proteins within the PDB data base was 
performed with the program DALI. Interestingly, significant structural similarity was 
found between Asf1 and ORF158. It is worth mentioning here that the BLAST search 
against all the protein sequences did not identify any similarity with the Asf1 protein. 
The sequence identity among these proteins was only 13%, however their three 
dimensional structures are highly homologous. The highest structural similarity is 
observed between ORF158 and the Asf1, yielding an rmsd of 3.4 Å for 73 Cα atoms, 
with 13% sequence identity. This observation suggests that there may be an 
evolutionarily conserved structural and functional relationship among these proteins, 
while at the same time the amino acid sequences of these proteins have diverged.  
5.3.9 Putative histone binding region 
Taking clues from the structural resemblance of ORF158 with Asf1, we hypothesize 
that ORF158 could be a histone binding protein and this property is required to 
regulate host histone H3 K79 methylation during SGIV replication. To verify our 
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hypothesis we inferred the ORF158 Histone proteins complex by superimposing 
ORF158 on Asf1 of the heterotrimer complex with Histone 3 (H3) and Histone 4 (H4) 
proteins.  In the inferred complex, the Histone proteins, particularly H3 protrudes into 
the negatively charged surface concave region and established several hydrogen 
bonding contacts with the nearby conserved residues. The key residue Val94 of Asf1, 
Ala 92 in the case of ORF158, occupies in the same pocket.  Figure 5.9 shows the 
inferred ORF158 complex model. Further to verify this hypothesis, we have 
expressed and purified Histone proteins (Figure 5.8) and examined the formation of 
complex with ORF158. The histone proteins are shown to co-localize with ORF158 in 
the nucleus of SGIV-infected cells (Figure 4.4). Furthermore we have also carried out 
Surface Plasmon Resonance (SPR) to obtain the binding affinities between them. 
ORF158 binds with Histone which in the order of 0.362µM indicates the formation of 
heterotrimer complex (Figure 5.10).  Based on our experimental observations and 
inferred Histone complex model, we propose that ORF158 binds with histone proteins 
in a way similar to Asf1. Figure 5.9 E shows the electrostatic surface potential of 
ORF158. The surface concave is located in a strong negative patch. It has been shown 
for Asf1 that a mutation of Val94 with Arg completely abolished the histone binding 
property of Asf1. This may be due to the introduction of large side chain residues in 
this pocket. A similar argument holds true for ORF158, mutating Ala 92 with a large 
side chain amino acid may affect its histone recognition. Future studies will be 
directed to understand the role of key residues in ORF158 to recognize histone 




Figure 5.1 Purification of ORF158L. A) Gel filtration profile of ORF158L on 
Superdex-30 gel filtration column (Amersham); B) Ion exchange chromatography of 





Figure 5.2 Molecular Mass determination by MS. A) MS results of Native ORF158L; 
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Figure 5.5 Characterization of protein structures by one-dimensional NMR 
spectroscopy: A). Upper panel: A typical one-dimensional proton NMR spectrum of a 
folded protein. Lower panel: A typical one-dimensional proton NMR spectrum of an 





Figure 5.6 Characterization of protein structures by two-dimensional NMR 
spectroscopy A) the 1H-15N HSQC spectrum of an unfolded protein ORF129; 








Figure 5.8 Purification of histone H3 & H4 complex. A) Chromatograph profile of 
histone H3 & H4 complex monoS column (Amersham); B) SDS page of purified 





Figure 5.9 Structure of ORF158L and models of ORF158L and histones complex. A) 
Overall structure of ORF158L; B) Structure comparison between ORF158L and Asf1; 
C) The model of ORF158L and histone H3 complex; D) The model of ORF158L and 
histone H3 & H4 complex; E) The electrostatic surface potential of ORF158L, blue 




Figure 5.10 SPR study of ORF158L binding to histone H3 & H4 complex.
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Table 5.1 Data collection and refinement statistics of ORF158L 
Data collection and refinement statistics 
Space group C2  
Unit cell dimensions (Å)  a=59.98, b= 41.01, c= 52.33   α=90, β= 95.32, γ=90.0 
   
Data set Peak Inflection 
  Resolution range (Å) 50-1.8  
  Wavelength (Å) 0.979 0.9792 
  Observed hkl 86250 73264 
  Unique hkl 11855 10223 
  Completeness (%) 99.9 99.9 
  Overall (I/oI) 14.8 12.3 
  Rsym a (%) 6.2 6 
   
 Refinement and quality   
  Resolution range [I>o(I)] 1.8 -20.0  
  Rwork b (no. of reflections) 0.2074(21617)  
  Rfree c  (no. of reflections) 0.2447(1093)  
  rmsd bond lengths (A) 0.006  
  rmsd bond angles  (deg) 1.3  
   
Ramachandran plot   
  Most favored regions (%) 86  
  Additional allowed regions (%) 13.2  
  Generously allowed regions 
(%) 0.9  












Achievements & Future experiments 
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6.1 Achievements 
In this thesis, we have presented the following achievements: 
1) We are the first to study the temporal and differential gene expression of 
Singapore grouper iridovirus (SGIV) by DNA microarray. To our knowledge, 
this is one of the first studies where DNA microarray technique and also real-
time RT-PCR were used for the investigation of fish viruses. (Chen et al., 
2006) 
2) We are the first to study the SGIV and host cell interaction at proteomics scale 
by using iTRAQ. (Chen et al., 2008) 
3) We are the first to demonstrate that ORF158L is a real protein encoded by 
SGIV. 
4) We are the first to characterize the function of ORF158L and show that 
ORF158L is involved in the regulation of histone H3 K79 methylation. 
5) We are the first to elucidate the crystal structure of ORF158L.  
6.2 Future experiments 
In future, we are going to further investigate the following scientific questions: 
1) We are going to study the mechanism about how ORF158L regulates host 
histone H3 K79 methylation and the consequences of the regulation of host 
histone H3 K79 methylation. 
2) By combining knockdown, DNA microarray and iTRAQ, we are going to 
carry functional studies of SGIV genes. 
3) With the help of NMR and X-ray crystallography, we are going to continue 
the structural studies of both viral structural proteins and viral non structural 
proteins. 
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4) Based on the functional genomics and structural genomics studies of SGIV, 
we are going to uncover the SGIV pathogenesis and provide valuable 
knowledge.  
5) Based on the functional genomics and structural genomics studies of SGIV, 
we are going to design new drugs and raise new strategies in the treatment of 
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